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ABSTRACT

Background/Introduction: Individuals with agrammatic Broca’s aphasia
frequently are treated at single word level, verb priming, or simple sentence
structure treatments. In this study, an impairment specific treatment such as
Verb Network Strengthening Treatment (VNeST) was explored as well as a
social functional approach such as Script Therapy. These two approaches
were assessed by the outcome measures of rate of speech, subject-verbobject production, and error rates during probe tasks.
Objective: To examine the impact of two treatment approaches: Script
Therapy and Verb Network Strengthening Treatment for two individuals with
chronic agrammatic Broca’s aphasia.
Method: A single subject multiple baseline alternating treatment across
participants’ design was implemented. Each participant received each therapy
for 9 weeks and both treatments were counterbalanced. Generalization
probes were administered on the second session of each treatment per week
to assess pre-to-post outcome measures including rate of speech, subjectverb-object production (SVO), and error rate. Effect sizes were calculated for
baseline through maintenance outcome measures. To analyze the intertherapeutic effects of the two treatment, the Percentage of data Exceeding
the Median was used.

x

Results: Both participants improved over the 18 weeks on rate of speech and
subject verb-object (SVO) production during probe tasks. For P1, Error rates
decreased from baseline to maintenance phases. Effect sizes were calculated
for the baseline to maintenance phases using the Busk & Serlin’s d2 formula
(1992). The effects size calculations were compared using the Beeson &
Robey (2006) benchmarks for lexical and syntactic metanalyses for aphasia.
For the baseline to maintenance effects, small effect sizes were found for
both participants for rate of speech. For P1, a medium to large effect was
noted for SVO production. P2’s effect size for SVO production revealed no
effect. Error rates for P1 revealed no effect. P2’s error rate produced a small
unfavorable effect.
Conclusions: Both participants benefitted from the two treatment
approaches in individual ways. It is possible that the multi-modal nature of the
training between VNeST and Script that engaged functional sentence
production and a linguistic approach for sentence production contributed to a
positive language change for these participants.
Keywords: Impairment specific approach, social functional approach,
agrammatic Broca’s aphasia, Verb Network Strengthening Treatment, Script
Therapy
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Chapter I

INTRODUCTION

Aphasia is an acquired neurogenic language disorder affecting the
production or comprehension of speech and possibly ability to read or write
(Cherney, Halper, & Kaye, 2008). It can be caused by damage to the brain,
often as a result of stroke or traumatic brain injury. Commonly in aphasia, the
damage occurs mostly in the left cerebral hemisphere. In some cases,
aphasia can affect the expressive and receptive components of language as
well as reading and writing. In conjunction with the linguistic aspects of
language, aphasia can also affect the social aspects of language leading to
social isolation and reduced participation in life activities (Bilda, 2011).
Aphasia often has profound effects on communicative interactions for
both everyday activities and exceptional life experiences. The inability to
access fluent and accurate language in routine daily interactions can have
tangible practical and psychosocial consequences. For individuals with
aphasia, life responsibilities that require particularly efficient language
production such as interviewing for a job may seem beyond reach.
Speech-language therapy for individuals with aphasia has
predominately focused on single aspects of language recovery including word
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retrieval and naming. Single aspects of language therapy have ranged from
simple cloze phrase word retrieval tasks to canonical and non-canonical
sentence production (Ballard & Thompson, 1999; Edmonds & Babb, 2011;
Edmonds, Nadeau, & Kiran, 2009; Martin, Fink, & Laine, 2004). For this
population, the specific treatments that target individual aspects of language
at the word or sentence level are necessary; however, it is critical to address
more functional communicative methods.
This study compares two well-known treatment methods for
agrammatic Broca’s aphasia: Verb Network Strengthening Treatment
(VNeST) and Script Therapy. Both treatment options stem from a different
aspect of language. VNeST focuses more on the building of the linguistic
levels such as subject, verb, and object phrases. Alternatively, Script therapy
focuses on the scripting of personal sentences to enhance functional
communication. Previous studies with agrammatic Broca’s aphasia failed to
examine a linguistic approach such as VNeST when compared to a functional
treatment approach such as Script therapy. A comparative study of these
methods will reveal which method of treatment is more efficacious.
In daily clinical routine, clinicians are compelled to choose their
methods of treatment to provide cost-effective treatment to patients with
aphasia. Although the methods under scrutiny, in this study, have the same
common objective of enhancing fluency in language production, these two
methods originate from different theoretical backgrounds: VNeST works at a
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more basic linguistic level of verb training and expects mastery at this level
will generalize to connected speech/natural language production, whereas the
‘Script’ treatment trains language production at a higher level, namely,
discourse or Script.
Thus, the outcome of the current study will have implications for these
theoretical view points on how to achieve fluent language production in
agrammatic aphasia. The comparison of these two treatments in this study
has not been previously researched with individuals with agrammatic Broca’s
aphasia. The relative cost of each treatment is inexpensive and both have
merits at improving language in this population. Therefore, the purpose of this
study is to examine and compare both treatments to one another and to draw
conclusions about the relative benefits of each treatment. In doing so, the
merits of each can be combined to provide individuals with aphasia with cost
effective therapeutic interventions that improve language. Additionally, it is
also important to determine which therapy: VNeST or Script is more effective
in promoting grammatically correct language for individuals with agrammatic
Broca’s aphasia.
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Chapter II

LITERATURE REVIEW

Aphasia: Fluent vs. Non-Fluent
There are two primary types of aphasia: fluent and non-fluent. Fluent
aphasia can be characterized by impairments in the reception of language,
with difficulties in auditory verbal comprehension or in the repetition of words,
phrases, or sentences spoken by others. An individual with fluent aphasia’s
speech is often easy and fluent, but there are difficulties related to the output
of language such as production. Non-fluent aphasia can be characterized by
difficulties in the articulation and production of language, but in most cases
there is relatively good auditory verbal comprehension (Clark, Charuvasta,
Miller, Shapiro, & Mendez, 2005). Chronic non-fluent aphasia is a lifelong
handicap that can often lead to social isolation, loss of autonomy, and
restricted social activity (Bilda, 2011).
To define the nature of non-fluent language production, investigators
have defined non-fluent speech as interrupted, awkwardly articulating with
great effort. Additionally, non-fluent speech as marked by difficulty with
articulation and long runs of words in a variety of grammatical constructions
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(Gordon, 1998). To further explain non-fluent and fluent speech, researchers
have used quantitative and qualitative measures such as speech rate,
pausing, phrase length, error production, self-correction attempts, semantic
content, syntactic content, and grammatical form (Ballard & Thompson, 1999;
Kiran & Thompson, 2003; Peach & Wong, 2004.) Fluent language production
can be determined by a number of linguistic factors including the ability to
produce appropriate morphology, lexical retrieval, sentence production,
grammatical form, and conversational exchanges (Ballard & Thompson,
1999; Edmonds & Babb, 2011; Edmonds, Nadeau, & Kiran, 2009; Martin,
Fink, & Laine, 2004; Nickels, 2002; Raymer & Ellsworth, 2002)
Agrammatic Broca’s aphasia
When defining the nature of agrammatic Broca’s aphasia, it can be
characterized by agrammatism or telegraphic speech, as well as deficits, in
morphology, lexical retrieval, syntax, and discourse or conversation. Typically,
individuals with Broca’s aphasia present with relatively intact comprehension.
A patient with agrammatic Broca’s aphasia speech production is
characterized by slow, halting speech, phonemic paraphasias, anomia,
recurring utterances or perservations, articulatory impairments, and possibly
apraxia of speech. Additionally, other aspects of language including the ability
to produce sentences can be impacted with agrammatic Broca’s aphasia.
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Sentence Production Deficits
Agrammatism is characterized by an inability to construct a
grammatical or intelligible sentence while retaining the ability to verbally
produce single words (Jacobs & Thompson, 2000). Individuals with
agrammatism present with an inability to speak grammatically because of
brain injury or disease, usually with simplified sentence structure and errors in
tense, number, and gender. Furthermore, individuals with agrammatism
present with difficulty comprehending and producing semantically correct
sentence. An example of agrammatic speech would be “Well…woman
and…..dishes .um, well, um…forget it”. Treatment options for agrammatic
aphasia vary with severity levels. Some treatments address training language
at the verb level. For example, Treatment of Underlying Forms (TUF) is an
approach that focuses on complex, non-canonical sentence structures and
operates on the premise that training underlying, abstract, properties of
language will allow for sentence production (Thompson & Shapiro, 2005).
Sentence production deficits in patients with agrammatic Broca’s aphasia
appears to be efficacious when the lexical and syntactic properties of (a) the
language deficit exhibited by the aphasic individuals and (b) the sentences
selected are for treatment and generalization.
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Morphological Deficits
One of the hallmarks of agrammatic-type Broca’s aphasia is a deficit in
the production of functional morphology (Thompson & Shapiro, 2005).
Individuals with agrammatic Broca’s aphasia may exhibit impaired lexical
processing which greatly impedes their ability to construct sentences and
communicate fluently. Morphology is defined as the study of internal word
structure and the way morphemes combine to form words (Lee, Mack, &
Thompson, 2012). Accordingly, individuals with agrammatic Broca’s aphasia
exhibit difficulty in understanding or producing complex lexical items that can
be characterized as having a morphological impairment. Individuals with
morphological impairments typically have left frontal damage which has
repeatedly been shown to have increased difficulty inflecting verbs as
compared to nouns. A selective impairment of verb morphology has been
linked to individuals with agrammatic Broca’s aphasia presenting with nonfluent, highly reduced speech lacking grammatical features, and a decrease
in the production of verbs and nouns (Ballard & Thompson, 1999; Edmonds &
Babb, 2011; Edmonds, Nadeau, & Kiran, 2009; Martin, Fink, & Laine, 2004;
Nickels, 2002; Raymer, & Ellsworth, 2002;Cameron, Wambaugh &
Mauszycki, 2010;Wambaugh & Ferguson, 2007; Peach & Reuter, 2010;
Wilkinson, Bryan, Lock, & Sage, 2010; Lee, Kaye,& Cherney, 2009; Basso,
2010). An example of morphological deficits from this study would be the
“man walk (omitted ‘ed’) on street”. Treatments for morphological deficits in
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agrammatic Broca’s aphasia have focused on verb infection tasks, subjectverb agreement, tense marking, and the use of subordinate conjunctions
(Dickey, Milman, & Thompson, 2008; Shapiro, Shelton, & Caramazza, 2000).
Another area of deficit for this population involves difficulty retrieving words.
Lexical Retrieval Deficits
Another linguistic factor that contributes to fluent language production
is the lexical retrieval of words. Deficits in lexical retrieval almost always
accompany some type of language disturbance associated with brain damage
(Friedmann, Biran, & Dotan, 2013). Individuals with agrammatic Broca’s
aphasia demonstrate deficits that are semantic in nature with difficulty
accessing the meaning, difficulty in accessing and producing the correct
forms of words. Furthermore, there may be substitution errors or paraphasias
or deficits with morphological forms of words. Additionally, individuals with
agrammatic Broca’s aphasia may demonstrate difficulty with grammatical
classes of regular and irregular verbs and grammatical suffixes. Similarly,
there may be difficulty with abstract words versus concrete word retrieval.
Treatments for lexical retrieval deficits has ranged from semantic feature
analyses, confrontational naming tasks, imagery and frequency of words, and
action verb naming (Peach & Wong, 2004, Thompson et al., 2013.; Youmans,
Youmans, & Hancock, 2011). Also, the grammatical categories such as
nouns, verbs, adjectives or prepositions may increase lexical retrieval
difficulty in individuals with aphasia. Furthermore, fluent language production

8

may be limited by poor grammatical structure of language during sentence
production and conversation.
Syntactic Deficits
Syntactic disorders are another linguistic factor that compromises
fluency in individuals with aphasia. Syntax is the study of the principles and
processes by which sentences are constructed in a particular language.
Deficits in syntax involve word order. In this study, P2 produced the phrase
“brush… teeth….men (The man was brushing his teeth) which illustrates
difficulty with number, tense, and word order.” Individuals with agrammatic
aphasia often have difficulty producing subject-verb-object sentences; which
are the most basic of syntactic forms. Additionally, the sentence type, the
number of clauses, and the verb tense can all play a role in the syntax of
individuals with aphasia. Agrammatic Broca’s aphasia was considered largely
a problem of sentence production that reflects an absence of grammatical
structure (Jacobs & Thompson, 2000; Thompson, Shapiro, Kiran, & Sobecks,
2003). In addition to sentence production deficits and word retrieval deficits,
individuals with agrammatic Broca’s aphasia may have difficulty
comprehending sentences that are reversible in which two nouns are equally
probable candidates for the role of the agent. The agent is the noun phrase
(NP) in the sentence (Jacobs & Thompson, 2000). Furthermore, individuals
with agrammatic Broca’s aphasia may have deficits in sentence production
and comprehension when the traditional noun phrase has been moved out of
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the canonical subject-verb-object position (e.g. Zack was chased by Quinn).
Discourse and conversation are more functional aspects of language that
require all areas of language: including sentence production, syntax,
morphology, lexical retrieval and comprehension to be intact.
Discourse/Conversation Deficits
Another linguistic factor that can affect fluent language production is
the ability to produce discourse or conversation. There are four primary
domains of discourse: expository, narrative, persuasion, and description.
Discourse requires the comprehension of individual words and sentences as
well as the integration across sentence representation to form a coherent
understanding of discourse. Individuals with agrammatic Broca’s aphasia
present difficulty both socially and linguistically processing discourse and
conversation due to the nature of the interaction (Cameron, Wambaugh,
Mauszycki, 2010; Wambaugh & Ferguson, 2007; Peach & Reuter, 2010;
Wilkinson, Bryan, Lock, & Sage, 2010; Lee, Kaye, & Cherney, 2009; Basso,
2010).
Evidence-Based Treatment Options for agrammatic Broca’s aphasia
Many studies have shown that speech-language treatment has a
significant and in some cases quite large treatment effects in persons with
agrammatic Broca’s aphasia (Edmonds, Nadeau, & Kiran, 2009). Such
studies have involved between-group, and/or within-group comparisons as
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well as studies that used single- case study controlled experimental designs.
The primary question of research in aphasia has been to determine the
therapeutic value of behavioral intervention in the recovery of language due to
acquired brain damage. Furthermore, the primary question of interest was
whether aphasia treatment improves language ability. Studies have been
influenced by treatments grounded in the psycholinguistic, cognitive theories,
and neuropsychological theories, and other models of language for oral and
written naming (Martin, Fink, & Laine, 2004; Kiran & Thompson, 2003;
Beeson & Hillis, 2001; Raymer & Rothi, 2001). Additionally, other studies
have examined the treatment effects of naming, word meaning, sentence
production, and comprehension in aphasia (Boyle, 2004; Thompson &
Shapiro, 2005). In the current study, a linguistic approach with an impairment
based treatment such as (VNeST) and a functional approach such as (Script)
are being compared.
There are various treatment options for agrammatic Broca’s aphasia.
(Youmans, Youmans, & Hancock, 2011; Youmans, Holland, Munoz, &
Bourgeois, 2005; Thompson, Shapiro, Kiran & Sobecks, 2003; Jacobs &
Thompson, 2000; Friedmann & Shapiro, 2003; Ballard & Thompson, 1999).
Such studies have addressed the training at both the word level and sentence
level. These studies have focused in using treatment options such as a
Semantic Feature Analysis (Peach & Wong, 2004), Treatment of Underlying
Forms (Thompson & Shapiro, 2005), and training of verbs (Thompson et al.,
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2013). Thompson et al. (2003) and Jacobs and Thompson (2000) examined
whether the training of syntactically complex sentences would result in the
generalization to less complex sentences in individuals with agrammatic
Broca’s aphasia. Additionally, individuals with agrammatic Broca’s aphasia
had difficulty comprehending sentences in which the noun phrases have been
moved out of the canonical (S-V-O) position as in passives or object clauses.
The training of syntactically complex sentences involves participants whom
will navigate through a series of steps that emphasize the verb and verb
argument structure as well as the ability to derive target sentences. In the
results, Jacobs and Thompson (2000) and Thompson et al. (2003) explained
that sentence production and comprehension are based on the linguistic
complexity. Furthermore, the comprehension training resulted in the
generalization to production; whereas, production treatment has little effect on
comprehension ability. Additionally, the comprehension treatment of trained
sentences was superior to the production treatment in facilitating
generalization in individuals with agrammatic Broca’s aphasia. One limitation
of this study was that the participants were not expected to produce the oral
reading of written sentences stimuli during comprehension training and so it is
possible that production improved because the comprehension treatment
contained a production component (Jacobs & Thompson, 2000). Thompson
et al. (2003) found that comprehension as well as production improved during
treatment. Furthermore, the comprehension treatment of trained sentences
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was superior to the production treatment in facilitating generalization in
individuals with agrammatic Broca’s aphasia. Other types of therapy for
chronic aphasia focus on using scripts to ensure participation in a full range of
vocational, recreational, and social activities.
Aphasic Severity and Chronicity
Individuals with agrammatic Broca’s aphasia benefit from a variety of
different treatments, even months and years beyond the time of onset.
Recently, emphasis has been put on the need for intensive aphasia treatment
to make the long-term neuroplastic changes associated with recovery and
rehabilitation following a stroke (Cherney, 2010). Yet, such treatment is not
always available. In fact, patients may be eligible for only a limited number of
treatment sessions following their acute hospitalization, and the costs of
communication treatment delivered to patients with chronic aphasia (beyond
12 months after onset) are not often reimbursable (Cherney, Patterson &
Raymer (2011). There is a need to identify treatments that are appropriate
and efficacious even when provided at low intensity, and easily administered
to individuals with chronic aphasia. On average for treatment intensity, 24-85
hours of treatment were offered as helpful for chronic non-fluent aphasics
(Cherney, Patterson, Raymer, Frymark, & Schooling, 2008). In the current
study, both participants received both treatments for a total of 18 weeks and
two sessions per week which were an hour long each.
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Theoretical Framework
Impairment Specific Approach vs. Social-Functional Approach
Two major approaches to aphasia treatment have emerged: One
approach was called an impairment specific approach to aphasia treatment;
the other approach was called the social functional approach. The
impairment specific approach addresses specific linguistic factors such as
naming, word retrieval, verb production, morphology, or sentence production
during treatment (Raymer et al., 2008; Peach & Wong, 2004; Thompson &
Shapiro, 2005; Thompson et al., 2013; Youmans, Youmans, & Hancock,
2011). The impairment specific approach focuses on the impaired language
structures or processes and provides direct intervention to improve the
weaker areas. The assumption of the impairment specific approach is that
treatment of specific aspects of language (e.g. naming) will have broad,
spreading effects across language areas and broader communication
systems. In the current study, the results of the baseline in-depth
assessments helped identify areas of language breakdown and language
intervention targets that will bolster the entire language system using a
treatment such as VNeST.
The second approach is called the social or functional approach. A
social functional approach is based on the individual’s communication
environment. Under the social functional approach, treatment goals and
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procedures are determined by shared decision making where functional
language tasks such as conversational discourse are explored. Treatment
focuses on functional language tasks such as narratives, sentence
production, and conversational discourse (Kagan 1998, Cruice, Worrall,
Hickson, & Murison 2003, Kagan et al, 2008).
Bottom-Up Approach vs. Top-Down Approach
The impairment specific approach to aphasia has been described as a
“bottom-up approach” (Basso, 2003), in which language components are
considered the building blocks of communicative abilities. Bottom-Up
Approach has focused on the idea that the weaker areas of language (i.e.
word retrieval) are targeted first and this helps to strengthen residual
language capabilities (Basso, 2003).
Social functional approaches have been described as “top-down”. The
social functional approach (Basso, 2003) focuses on the social participation
for everyday life activities. Script Therapy is based on a social functional
method for communication. A simple comparison of a “bottom-up” to a “topdown approach” might lead to the idea that both approaches will help identify
which treatment is best for specific clients to achieve certain outcomes. For
the purposes of this study, both an impairment specific approach such as
Verb Network Strengthening Treatment (VNeST) and a functional
communication approach such as Script Therapy will be analyzed to see what
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method of treatment causes change to the pre-to-post outcome measures of
rate of speech, SVO production, and error rate.
Script Therapy
Script therapy was chosen as it is a functional approach to aphasia
therapy that can facilitate participation in personally relevant conversational
activities. Previous studies have utilized group treatment and training of the
communication partner to help improve evidence based practice in individuals
with aphasia (Elman & Bernstein- Ellis, 1999; Kagan, Black, Duchan,
Simmons-Mackie, & Square, 2001). Additionally, treatment studies have also
utilized computerized technology to improve language production and
comprehension in aphasia.
Script training is a functional approach to aphasia therapy that can
facilitate participation in personally relevant activities (Cherney, Halper,
Holland, & Cole, 2008; Youmans, Youmans, & Hancock; 2011; Bilda, 2011;
Youmans, Holland, Munoz, & Bourgeois, 2005; Cherney, Halper, & Kaye,
2011). Scripts guide and facilitate the identification of participant’s
conversations and actions involved in social situations. Furthermore, Scripts
can provide knowledge including the understanding, remembering, and
recalling of the temporal organization of events in a routine activity.
Youmans et al. (2005) conducted a study on two individuals with Broca’s
aphasia who intensively practiced speaking Scripts as monologues and
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conversational contexts. In this study, Scripts were trained one phrase at a
time. A cueing hierarchy was used to train new material: phrase repetition,
choral reading of passages and then independent production (Youmans et al.
2005). Once a script was mastered, generalization training was implemented.
During the generalization phase, monologue scripts were practiced in
conversational form with novel conversational partners. Both participants were
assessed on their ability to produce automatic speech production as measured
by relatively errorless speaking, increased speaking rate, and consistency in
using the scripts. Both participants were measured using the percentage of
scripts correct, error rate, and the speaking rate. Percentage of script words
was the number of script words produced divided by the total number of words
in the script. Circumlocutions and substitutions were excluded from the total
number of words. The error rate was defined as non-communicative words or
phrase repetitions, fillers, pauses of 3 seconds or more, and unrecognizable
utterances. Speaking rate was the duration of each script and a word per
minute rate was calculated. The results of this study suggest that script training
was an effective treatment with individuals with non-fluent aphasia (Youmans
et al. 2005). Additionally, both participants produced an increase in the
percentage script correct scores and an increase in speaking rate.
Recently, the method of script training has changed from a typed script
to a computerized program for script production (Bilda, 2011; Cherney, Halper,
Holland, & Cole, 2008; Cherney, Halper, & Kaye, 2011; Cherney, Halper,
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Holland, Lee, Babbitt, & Cole, 2007). This computerized treatment is a cost
effective medium for therapy and emphasizes the development of
conversational skills in everyday life. The computerized script therapy program
is called AphasiaScripts (Cherney et al., 2008). AphasiaScripts is a software
program using an animated agent that serves as a virtual therapist for Script
training. Additionally, the visual therapist is programmed to produce natural
speech with correct movements of the articulators for speech. AphasiaScripts
provides repeated opportunities for the client to practice individualized
conversations that have been pre-recorded. Script training has multiple types
of cues including oral motor cues, written words, and choral speaking of the
virtual therapist. Computerized script training has three phases including: the
client will listen silently to the entire script. Next, each sentence that is part of
the client’s conversational turn is practiced and the entire conversation is
practiced repeatedly in turn taking with the virtual therapist.
The treatment protocol of script therapy involves the development and
automatization of personal scripts and then script practice (Cherney et al.
2008). The initial 4 weeks of therapy, are devoted to the development of the
conversational scripts by a speech-language pathologist in partnership with the
participant with aphasia. The participant will identify and prioritize three script
scenarios (Cherney et al. 2008; Cherney et al. 2007; Cherney et al. 2011).
Script practice involves baseline measures taken to ensure script reliability.
Additionally, the speech-language pathologist will instruct the client on the use
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of scripts at home for a minimum of 30 minutes per day (Cherney et al. 2008;
Cherney et al. 2007; Cherney et al. 2011). The client is responsible for
progressively removing the cues and the client makes weekly visits to the
speech language pathologist to ensure script practice is ongoing.
Quantitatively, individuals with aphasia using script therapy in numerous
studies were measured based on content including the number and percent of
script related words, grammatical complexity including the number of
morphemes, nouns, verbs, and modifiers as well as rate (Cherney et al., 2008;
Cherney et al., 2007; Cherney, et al, 2011; Bilda, 2011). In previous studies,
the use of Script therapy with Broca’s aphasia has led to increased content,
grammatical productivity, and rate of production (Cherney et al., 2008; Cherney
et al., 2007; Cherney, et al, 2011; Bilda, 2011). Additionally, the individuals with
agrammatic Broca’s aphasia used the scripts to generalize to more social
communication exchanges. Furthermore, other types of therapy programs
have been found to be beneficial for agrammatic Broca’s aphasia including
Verb Network Strengthening Treatment (VNeST).
Verb Network Strengthening Treatment (VNeST)
In recent years, verb-centered treatment programs have emerged to
address lexical retrieval deficits in sentence production (Edmonds & Babb,
2011). Such verb-centered programs have included sentence completion,
cueing hierarchies, picture naming, and semantic feature analysis for verbs and

19

retrieving verbs. These previous treatment programs emphasize improvements
in the retrieval of trained verbs which can result in improved sentence
production with those verbs. However, increased lexical production does not
necessarily result in improved sentence production. Additionally, generalization
of these verb-centered programs has led to mixed findings.
Verb Network Strengthening Treatment (VNeST) is defined as an
impairment specific semantic treatment that aims to improve lexical retrieval of
content words in sentence context by promoting systematic retrieval of verbs
and their thematic roles (Edmonds, Nadeau, & Kiran, 2009). Individuals with
agrammatic Broca’s aphasia may benefit from the use of predicative
components of the semantic representations of concepts. Predicative
components are features of nouns that add meaning (Edmonds et al., 2009).
For instance, running, leaping, barking, and whining can be predicative
components of a dog concept representation (Edmonds et al., 2009). VNeST
may also increase the semantic representations of the verbs. The basic task of
VNeST is to generate agent and patient pairs to a target verb (Edmonds et al.,
2009). For example, these agent and patient pairs could be ‘chef’ to ‘sugar’ or
‘carpenter’ to ‘lumber’. Furthermore, the intent of VNeST is to strengthen the
connections between the verbs and their thematic roles. Edmonds et al. (2009)
conducted a study on four aphasic individuals: two individuals had transcortical
motor aphasia and the other two participants had conduction aphasia. All four
individuals were evaluated during a connected speech task using a picture
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description and Cinderella narrative task to measure their discourse abilities. A
Systematic Analysis of Language Transcripts (SALT) (Miller & Iglesias, 2012)
was used to measure each participant’s number of utterances and mean length
of utterances. A complete utterance was considered one that used an agent,
verb, and object. Before treatment, participants showed deficits in producing
complete utterances from 50% to 62%. Additionally, the number of phonemic
and semantic errors were identified and verb naming accuracy varied across
participants before treatment. Sentence elicitation pictures were developed for
baseline and treatment probes and a control task of adjective retrieval was also
used during this study. The treatment stimuli consisted of 10 trained verbs and
6-8 cards for each verb containing 3-4 agents and 3-4 patients related to each
verb (Edmonds et al., 2009). Additionally, questions of who, what, where, when,
and why and 12 sentences were used that contain the inappropriate agent,
inappropriate patient, and thematic reversal. VNeST was administered twice
per week for 2-hour sessions. Participants performed the treatment steps that
aimed to strengthen the semantic meaning of the target verb and to promote
stronger associations between the verb, related agents, and patients.
In the results, the correct production of the agent, verb, and patient in
the picture description depicting trained actions increased for all participants
except one participant with conduction aphasia.

All participants achieved

generalization of untrained verbs. Additionally, all participants were able to
generalize both treated and untreated verbs. Additionally, all participants
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showed an increase in single noun retrieval and three of the four participants
improved on agent-verb-patient retrieval in sentences. Three of the four
participants showed improvement in the ability to produce utterances
containing a relevant subject, verb, and object with an increase in utterances
overall. Participant 4 had conduction aphasia and did not show improvements
in connected speech on any measure. Overall, VNeST does generalize to
nouns and verb retrieval in sentence production.
Edmonds and Babb (2011) examined the effects of VNeST with two
participants with more moderately severe Broca’s aphasia. The treatment
protocol was the same as in Edmonds et al. (2009) as the participants were
rated on their single word naming of objects and actions, evaluated on
sentence production, evaluated on the production of correct information units
in discourse, and the ratings of functional communication as based on the
Communicate Effectiveness Questionnaire (CETI; Lomas et al., 1989). In the
results, participant 1 exhibited a small increase in noun retrieval; whereas,
participant 2 resulted in a significant increase in retrieval of nouns. Additionally,
both participants exhibited an increase in words from pre-to-post treatment in
their production of correct information units and their use of neologisms
decreased. On the CETI scale, both participants demonstrated a significant
increase in ratings of functional communication (Edmonds & Babb, 2011). A
few limitations of this study included the necessity to include the relationship
between verbs and their thematic roles, treatment intensity and duration is
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another limitation as well as the participant factors, generalizability outcomes,
cognitive linguistic factors, and access to the communication partners.
Problem
There is limited previous research on individuals with agrammatic
Broca’s aphasia and their ability to consistently produce sentences. In previous
research, there were many approaches to treatment with individual with
agrammatic Broca’s aphasia, but few have been cost effective and addressed
treatment of language skills in realistic contexts. Additional factors that may
contribute to the variability with this agrammatic Broca’s population are length
of time between onset of neurological event and the length of time of treatment.
For some people, aphasia will be temporary, resolving in the first few days or
even hours after their stroke or brain injury. Others will have a long recovery
of months or years. Some people may improve to a degree in the first few
months, but will still live with a severe aphasia that affects their ability to
communicate for the rest of their lives. It is rare for people to make no
improvement at all.
The typical pattern of recovery is for aphasia to be at its worst initially,
with spontaneous recovery occurring most rapidly in the first few days, weeks
and even months. Spontaneous recovery is a term used to describe the
improvement that happens as the brain heals from a stroke or brain injury.
Traditionally, experts have advised people that there was a finite period of time
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during which the brain would heal, after which improvement was no longer
likely. While there is disagreement over the length of time, spontaneous
recovery may occur within the first year. There has long been general
agreement that there was a “window of opportunity” for improvement to be
capitalized on by therapy, after which people improved mainly by adapting to
their aphasia (Smania et al.,2010).

Few studies have used these two

treatments: Script Therapy and Verb Network Strengthening Treatment with
individuals with aphasia.
Aim of the Study
The aim of this study was to determine the efficacy of the two treatment
approaches: Script and VNeST for the agrammatic broca’s aphasic population.
Significance of the Study
In the current healthcare situation, clinicians are expected to make
informed decisions in the choice of treatment that yields results at a lower or
minimal cost. Therefore, it is important from an evidence based practice
perspective to explore further treatment options. For the purposes of this
research, what remains unclear is the effectiveness of these two treatments on
language outcomes at the word, sentence and discourse level measures in
individuals with agrammatic Broca’s aphasia. The comparison of the two
treatments in this study has not been previously researched with individuals
with agrammatic Broca’s aphasia. In examining the feasibility of combining
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treatment approaches for individuals with agrammatic Broca’s aphasia, it is
important to use of a single subject multiple-baseline alternating treatment
across participants’ design that allows for conclusions about cause and effect,
interval validity, and feasibility.

Research Questions/Hypotheses
1.) RQ1. Does the combination of Script and VNeST interventions
improve language outcomes in individuals with chronic agrammatic
Broca’s aphasia during standardized assessment measures?
H1a. Participants will increase language skills including naming,
comprehension, narrative production and cognitive skill areas from pretreatment to post-treatment.
2.) RQ2. Do the participants show gains in word level, sentence level,
and discourse level measures obtained from baseline to maintenance
phases?
H2a. Participants will show gains in rate of speech, SVO production,
and decrease error rates obtained from language samples at baseline
through maintenance phases.
3.) RQ3. What are the relative effects across interventions on word,
sentence, and discourse level measures obtained from language
samples?
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H3. Large effect sizes will be found on word, sentence, and discourse
level measures across interventions.
3a.) RQ3a. What are the relative effects for each participant on
word, sentence, and discourse level measures across interventions?
H3a Large effect sizes will be found on word, sentence, and
discourse level measures for each intervention per participant.
4.) RQ4. How does Script compare to VNeST intervention for improving
language outcomes in individuals with chronic agrammatic Broca’s
aphasia?
H4a. VneST will be more efficient in improving language outcomes for
the chronic agrammatic population.
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Chapter III

METHOD

Study Design
This study used a single subject multiple baseline alternating treatment
across participants’ design. This study design included four phases: baseline,
treatments 1 or 2 and then reversed, post treatment and a 4- week
maintenance phase to reassess probe tasks. Two participants diagnosed with
agrammatic Broca’s aphasia by the primary investigator during inclusion testing
participated in the study. Both participants entered the baseline treatment and
the treatments were counterbalanced against one another. Weekly randomized
probe tasks (video, picture description/sequencing, and procedural narratives)
were administered during the second session of each week during the study.
Additionally, a picture description probe task was administered at baseline,
between treatments, and post treatment to control for learning effects.

Single Subject Designs

Due to the limited number of individuals with aphasia and the
heterogeneity of the disorder, single subject designs are often the nature of
research in this area. Most treatment studies in aphasia have less than five
participants. Use of single subject multiple baseline alternating treatment
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designs allow for the careful selection of study participants for the specific
nature of their language impairment, precisely describing the components of
treatment as well as the outcome measures, and carefully gathering reliability
data. Furthermore, through the use of single subject designs, researchers
have discovered treatments that are effective for patients with certain types of
language impairments (Thompson, 2006, Kiran & Thompson,2003; Edmonds
et al., 2009; Martin et al., 2004, Beeson & Robey, 2006).

Knowing the effects of specific types of treatment for patients with
certain language impairments as well as understanding the extent to which
these treatments result in generalized language use is important particularly
in the current health care climate, which imposes limitations on the treatment
that can be provided. Treatment outcome research measures changes during
or after the treatment process and addresses a variety of questions including
cost of treatment, quality of care, and achievement of functional change in the
client (Olswang, 1993). The outcome or benefits of treatments are
documented as “real world” conditions. Demands for data that show
significant, cost-effective changes in client behavior following interventions
have resulted in an increase in outcome research. Single subject designs are
less focused on exploring how treatment alters behavior but rather the
treatment is associated with important changes in a client’s life that
contributes to ecological validity (Schwartz, 2010, Olswang, 1993, Robey,
2004). Treatment outcome research yields meaningful effects when the
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intervention comes packed into a less costly program (Fey & Finestack,
2009). Additionally, treatment outcome research can help increase external
validity and generalizability to real-world clinical applications and identity
specific treatment benefits for smaller populations (Robey, 2004).
Feasibility of Single Subject Multiple Baseline Designs. The
principle purpose of feasibility research has less to do with measuring
treatment outcomes than with evaluating the clinical viability of untested
interventions. Publications of feasibility research is pivotal to the development
of a strong research based that helps to support evidence based practice.
Additionally, publications of these works can encourage discussions across
research including advances in interventions, validating outcome measures,
and strengthening research designs. Effectiveness studies or treatment
outcome research can evaluate the effects of efficacious treatments across
broader, more typical populations and under broader, more typical clinical
conditions (Fey & Finestack, 2009; Schwartz, 2010; Olswang, 1993).
The feasibility of multiple baseline designs incudes that a withdrawal of
an effective treatment is not required to demonstrate the functional
relationship between independent variables and dependent variables.
Furthermore, the generalization of the behavior change is monitored through
the design. Replication of multiple baseline designs can provide evidence that
the data paths change in predictable manners from baseline to intervention
through maintenance phases.
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Effect sizes and Single Subject Designs. An effect size is computed
for each empirical study investigating a specific treatment and then is
averaged across studies to provide a summary statistic on the interventions
effectiveness (Rogers & Graham, 2008). Single subject designs can be used
to test whether a treatment is responsible for observed changes in
performance. Additionally, Rogers and Graham (2008) discuss the major
threats to interval validity are controlled by within and between subjects’
comparisons, and external validity is enhanced through systematic
replication. In single subject designs studies, participants serve as his or her
own controls with performance prior to as well as during and/or after
intervention which is repeatedly measured to establish performance patterns
across baseline through maintenance phases which was used in this study.
Experimental control. One method for establishing experimental
control involves the introduction and withdraw of treatment. A multiple
baseline design involves implementing a stable baseline of performance
followed by treatment to determine changes in the dependent variable,
followed by the withdrawal of treatment to determine whether performance
returns to baseline levels, followed by treatment again. Multiple baseline
designs involve the staggering of both within and between subject
comparisons. In multiple baseline studies, researchers establish a baseline
pattern of performance for each participant, then treatment is implemented
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with one participant to determine whether it influences the performance in a
predictable fashion (Rogers & Graham, 2008).
To demonstrate interval validity in single subject designs, performance
within the same participants is compared before and during treatment
implementation (Koutsoftas, Harmon, & Gray, 2009). In a multiple baseline
across participants’ design, experimental control is demonstrated when
performance changes for the participants who begin different treatments
(McReynolds & Thompson, 1986). With regards to this study, both the weekly
probe tasks and the mid-treatment picture description tasks were
administered for further demonstration of experimental control.
Institutional Review Board
Completed applications were submitted to Hackensack University
Medical Center and LaSalle University Institutional Review Boards (IRB).
Approvals from both Institutions were received (Appendix A & B). After
obtaining IRB approvals, participant recruitment started. Hackensack
University Medical Center and Seton Hall University IRB approval #
Pro00006239 (continuation approved on 4/27/17) and LaSalle University IRB
approval # 15-03-009.3-17-RC (continuation approved on 3/27/17).
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Timeline for Study

Figure 1. Timeline for study over the course of 26 weeks
The length of the study was 26 weeks long. After signed consents, the
first two weeks were devoted to pre-treatment testing and baseline probe
measures. After the baseline probes measures were administered, both
participants were randomly selected through a coin toss and administered
alternate treatments. P1 received Script therapy and then VNeST. P2
received VNeST then Script. After the first nine weeks, the treatments were
stopped and both participants took a two-week break from treatment. Once
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the break was over, the participants were re-evaluated using the midtreatment probe and the second alternate treatment was implemented. After
18 weeks, the final probes were administered and the four-week maintenance
probe measures were assessed.
Method of Recruitment
All recruitment efforts respected participants’ right to privacy and
confidentiality in the research site. Speech-language pathologist who cover
the LaSalle University Clinics approached the potential participants and asked
if they were interested to participate in the study. Once the participant agreed
to the study, the principal investigator explained the details of the study. The
patient must be competent of understanding the facts about the research and
were able makes decisions. The primary investigator delivered all the
necessary information about the study, including the goals, benefits, and
potential risks.
The participants who agreed to participate in the study received a
consent form. The consent forms stated the researcher’s affiliations with
Seton Hall, Hackensack, and LaSalle University, the purpose of the research,
expected study duration, rights of the patients, benefits and risks and the
description of the procedure. Both participants signed the informed consent
form.
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Participants
Sampling Procedure
Two participants were recruited from the LaSalle University SpeechLanguage-Hearing-Community Clinic in Philadelphia, PA. This study used a
convenience-sampling technique where participants were selected based on
their accessibility to the research and type of aphasia.
Inclusion Criteria
The participants met several inclusion criteria including (a) diagnosis of
aphasia quotient of <50 on the Western Aphasia Battery (WAB-R;
Kertesz,1982), (b) monolingual English speaking, (c) right handiness prior to
stroke, (d) considerable verb retrieval deficits as diagnosed from the
Northwestern Assessment of Verb Production Battery (NAVS; Thompson,
2002), (e) negative history of diagnosed learning disorder, and (f) no worse
than a composite score of a mild deficit on the Cognitive Linguistic Quick Test
(CLQT; Helm-Estabrooks, 2001) (g) Both participants were in the intended
age ranges of 25-65 years old. Additionally, the Apraxia Battery for Adults 2nd
Edition (ABA-2; Dabul, 2000) was administered to determine the presence or
absence of speech, oral or limb apraxia. All participants earned a high school
diploma or better. Aided visual acuity was judged within normal limits. Hearing
was unaided and judged as within normal limits. Participants were not to be
enrolled in any other speech and language therapy at the time of the baseline
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testing phase of the study. Both participants demonstrated adequate reading
of single words.
Exclusion Criteria
Three exclusions for this study included participants with greater than
a mild cognitive impairment including participants with a history of previous
learning disability, participants already enrolled in treatment, and participants
with other types of aphasia. An additional participant was evaluated and
excluded due to the type of aphasia.
Participant Demographics
P1 was a 32- year-old right-handed woman with 16 years of education.
In 2007, P1 was diagnosed with a craniopharyngioma and received a partial
resection. At that time, there were no reported problems with speech and
language due to the tumor. Twenty months before beginning the study, P1
had a left hemispheric stroke. According to CT scans, she sustained a
massive left middle cerebral artery stroke (MCA) extending from the
striatocapsular territory extending to the frontal lobe. Subsequent to her
stroke, she underwent a craniotomy to relieve pressure. Prior to her stroke,
P1 was a college student finishing all but one class as a Criminal Justice
Major. Immediately after her stroke, P1 received speech and language
therapy at a rehabilitation hospital, but discontinued it eight months prior to
participating in the current study. Additionally, she had a history of seizures
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after the stroke with which she takes the medication Gabapentin. P1 did not
report any seizure activity six months prior to the stroke, during the study or
after the maintenance period. P1 passed the hearing screening prior to the
study at 30 db.
P2 was a 46-year-old right-handed male with 16 years of an
education. Twenty- six months prior to the study, he had a large severe MCA
with mass effect from the parenchymal edema the invoking the
temporoparietal region as noted from his CT scan. P2 passed the hearing
screening at 35 db. Prior to his stroke, P2 worked as a business manager. P2
received speech therapy for approximately 15 months after his stroke, but he
had discontinued this therapy six months prior to enrollment in this study. This
participant had a medical history of high blood pressure and depression after
the CVA.
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Table 1.
Participant Demographic Information
Participant

Age &

Years of

Handedness

Years

Site of

Occupation

Gender

Education

Of Subjects

since

Lesion

Prior to

Onset
P1

32,

16

Right

Female
P2

46,

20

Illness
MCA

Student

MCA

Manager

months
16

Right

Male

26
months

Procedures
Prior to the initiation of the study, approval for all procedures was
granted by the institutional review board associated with the primary
investigator’s affiliated universities (LaSalle University and Hackensack
University Medical Center). The following section outlines: a) Language
testing to determine eligibility, b.) Post-treatment testing, c.) Procedures to
assess pre-to-post language measures.
Pre-treatment Language Testing
All participants underwent initial eligibility testing including: The
Western Aphasia Battery-Revised (WAB-R; Kertez, 2006), The Cognitive
Linguistic Quick Test (CLQT; Helm-estabrooks, 2001), the Apraxia Battery for
Adults (ABA; Dabul, 2000), the Boston Naming Test (BNT; Kaplan,
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Goodglass and Weintraub, 1983), The Northwestern Verb Production
Battery/The Northwestern Assessment of Verbs and Sentences (NAVS;
Thompson, 2002), and the use of the elicitation materials from Nicholas and
Brookshire, 1993). Additionally, all pre- and post-treatment testing was
conducted by the primary investigator.
Table 2.
Pre-Treatment Assessment Scores
WAB-R
P1

46.5

BNT
N =60
31

P2

42.5

30

NAVS
N=22
11

CIUS

CLQT

ABA-2

14

8

10

183
Mild
Attention,
160 Memory,
31 Executive
Functions,
15
Language,
(Severe) ,91
Visuospatial
Skills
191
WNL
Attention,181
Memory,24
Executive
Functions
11
Language(Severe), 83
Visuospatial
skills

Testing Materials (Reliability and Validity)
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Western Aphasia Battery-Revised (WAB-R, Kertesz, 2006). All
participants’ aphasia profiles were obtained by administering the WAB-R
(Kertesz, 2006). This standardized test was used to obtain an aphasia
quotient, which is a composite score that includes picture description, auditory
comprehension, repetition, spontaneous speech, and naming tasks.
Participants were identified as having agrammatic aphasia which includes
difficulty with language production characterized by short utterance lengths
with one to two words, relatively adequate comprehension, poor repetition,
reduced fluency, and decreased naming.
Reliability and Validity of Western Aphasia Battery-Revised. The
WAB-R was standardized on 4 populations:150 patients of all etiologies
including 365 aphasics and 161 total controls. Criterion Validity indicated the
extent to which a test may be used to estimate an individual’s standing in
respect to their disability with a Pearson Correlation Coefficient score of (.96),
an internal consistency score of (.91) indicating a high internal
consistency. An intra-rater reliability correlations of 10 tests administered
indicated that correlations were obtained for each subsection and judged as
high. Interrater reliability (range .98 to.99) correlations were consistent over 8
raters. For test-retest reliability, the WAB-R yielded a score of (.99). A
criterion for differentiating aphasics from controls is validated-high construct
validity, test-retest reliability, intrarater, and interrater reliability was shown.
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Boston Naming Test Reliability and Validity (BNT; Kaplan,
Goodglass & Weintraub, 1983). This test consisted of a 60- item
confrontation naming test. All participants were administered the BNT to rule
out confrontation naming deficits. The participants in the study scored less
than 30 on the Boston Naming Test. An interjudge reliability on 12 out of 60
BNTS scored from 85.9%-95.2%. The interjudge reliability score was (.98).
Intercorrelation scores were (.81) for the BNT.
Cognitive-Linguistic Quick Test (CLQT, Helm-Estabrooks, 2001).
This assessment assessed five cognitive domains: attention, memory,
language, executive functions, and visuospatial skills. The CLQT version
provides a standardized scoring system that permits analysis of language,
visuospatial planning skills, and conceptualization of time. The CLQT was
normed on 171 non-clinical cases and 38 clinical cases, including TBI.
Reliability and Validity for the CLQT. For test-retest reliability, the
CLQT was administered to 46 examinees on 2 separate occasions. The testretest coefficients ranged from 0.03 and 0.81 for each subtest and from 0.61
to 0.90 for cognitive domains. Interscorer agreement was (.86) among two
scorers. Test content validity was rated as (.74) for found for the Composite
severity rating and each subtest.
Northwestern Assessment of Verbs and Sentences (NAVS,
Thompson, 2002). The NAVS was designed to examine comprehension and
production of action verbs, production of verb argument structure in sentence
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contexts, and the comprehension and production of canonical and noncanonical sentences in individuals with language disorders resulting from
neurological disease. There were five subtests including the Verb Naming test
(VNT), the Verb Comprehension Test (VCT), the Argument Structure
Production Test (ASPT), the Sentence Production Priming Test (SPPT), and
the Sentence Comprehension Test (SCT). A total of 103 individuals with
aphasia participated in standardization. Fifty-five presented with non-fluent
aphasia and 48 were fluent. Aphasia type was determined by the WAB-R. For
reliability data from 44 of the 103 individuals with aphasia were used to
examine internal reliability and external validity. Correlational analyses were
conducted on all items across sentence types. Participant performance on all
items on the VNT indicating a high degree of internal reliability. The same
patterns were demonstrated in the SPPT and the SCT with significant
correlations between all individual items. For interrater reliability, no
significant differences were found across raters per subtest. (P=.919 p=.999). During the assessment of external validity, significant correlations
were found between all NAVs subtests and WAB-R aphasia quotient scores.
The NAVS appears to be a valid measure for verb and sentence
comprehension and production.
Correct Information Units/agrammatic profile (CIUS, Nicholas &
Brookshire, 1993). The participants’ agrammatic profiles were determined for
eligibility by using narrative speech samples from the elicitation materials from
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Nicholas and Brookshire. To assess interjudge reliability, the two scorers who
scored the transcripts for this study both independently scored a
systematically selected, representative sample of the transcripts (10 speech
samples for each of 6 non–brain damaged and 6 aphasic subjects). The
aphasic subjects were representative of the group in severity and type of
aphasia. Four of the subjects exhibited fluent aphasia and 2 exhibited
nonfluent aphasia. Point–to–point interjudge percent agreement for number of
words and number of CIUs was calculated with the following formula: [total
agreements/ (total agreements + total disagreements] x 100]. Interjudge
reliability exceeded 98% for words and 90% for CIUs for all 12 subjects and
did not appear to be strongly correlated. Intrajudge reliability exceeded 99%
for words and 95% for CIUs for all 6 aphasic subjects.
Apraxia Battery for Adults-2 (ABA-2; Dabul, 2000). All participants were
administered the ABA-2 (Dabul, 2000). The ABA-2 was administered to
determine the presence or absences of speech, oral or limb apraxia.
Reliability and Validity of the Apraxia Battery for Adults. Test
reliability, investigated by the coefficient alpha, was rated as high (reliability
coefficients of .83 to .99 were obtained for all subtests). Content, criterionrelated validity, and construct validity were studied through a review of the
literature, item analysis, comparing the results of the ABA-2 to the Porch
Index of Communicative Ability, comparing differences in scores on the ABA-
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2 of various subpopulations, and examining the correlations of the subtests.
Results indicate that examiners can use the ABA-2 with confidence.
Experimental Treatment Tasks
Table 3.
Counterbalanced Treatments per Participant
P1

P2

Script Therapy: weeks 1-9

VNeST: weeks 1-9

VNeST: weeks 9-18

Script Therapy: weeks 10-18

Procedures for Script Therapy Treatment
Script Therapy Stimuli. Prior to the treatment phase, all participants
worked in conjunction with the primary investigator to develop the three script
topics including a hobby, a vacation and a phone call scenario. Each topic
was meaningful, relevant, and matched to each participant’s communication
level. The communication level was determined by the participants’ ability to
produce short versus more complex sentences as well as word retrieval.
After the scripts were documented, three phases occurred for each
participant to learn the script. First, the participant listened to the entire script
as read aloud by the speech-language pathologist. Second, each sentence
or phrase or conversational turn was practiced repeatedly. Third, the
conversation was practiced with the primary investigator while cues are
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provided based on the participants needs. These cues include a written word
cue, hearing the primary investigators’ voice during choral speaking, and
watching oral motor movements (Cherney, Halper, & Kaye, 2011). These
cues faded over time so the participants practiced the conversation with the
primary investigator, without cues, as in a real conversation. All participants
practiced the three individualized scripts for three weeks each for a total of
nine weeks. Additionally, all participants were asked to practice at least 30
minutes a day, six days per week for a minimum practice time of three hours
a week. The Script data per participant can be found in figures 1 & 2.
Treatment structure for Script Therapy. Each participant was seen
individually for two 60 minute sessions for nine weeks. Treatment sessions
were structured to allow at least three 10-minutes episodes of practicing
scripts, interspersed with approximately four brief periods of relaxed open
conversation. At the beginning of each session, the participants were audioand video-recorded while practicing the scripts or the targeted verb
sentences. As the scripts became mastered, treatment sessions ended with
approximately 10 minutes of conversation practice to promote flexible use of
scripts. The home practice sessions were prescribed twice daily for 15
minutes each during which the participants practiced their scripts via a tape
recorder. The participants reported consistency of home practice weekly
through daily text messages to confirm practice.
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Blocked Practice. Scripts were trained one phrase at a time, using a
blocked practice approach to promote acquisition. The cueing hierarchy
consisted of clinician modeling the target phrase, clinician and participant
modeling in unison, clinician and participant productions of the phrase in
unison, clinician and participant productions of the phrase in unison with
clinician fading participation, independent productions by the participants with
written cues and no cues.
Random Practice. When three phrases of scripts were produced
independently without cuing or support with 90% accuracy, random practice
of scripts will be initiated for these acquired phrases. First, the clinician
randomly selected and pointed to cue cards used to train the phrases.
Participants were instructed to produce each phrase only once before moving
on to the next phrase. Feedback on the accuracy of speech sound production
and articulator placement/positioning was provided in a summary fashion
after each episode of random practice.
Procedures for VNeST Stimuli Development
Stimuli consisted of 10 cards containing the names of 10 target verbs,
six to eight cards for each verb containing three to four agents and three to
four patients that formed three to four pairs related to each verb. Additionally,
five cards containing the words who, what, where, when, and why and 12
sentences for semantic judgment and 12 sentences containing the target verb
broken into four categories:
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A. correct (“The designer measures the room.”),
B. inappropriate agent (“The infant measures the lumber.),
C. inappropriate patient (“The chef measures the television”),
D. thematic reversal (“The room measures the designer”)
(Edmonds & Babb, 2011).
VNeST was administered two times per week for two one hour
sessions for a total of 9 weeks. During treatment, both participants were
asked to produce orally three to four thematic pairs (e.g. carpenter and
lumber) for a provided verb (e.g. measure). When the participants were
unable to produce a word, written options on cards were provided. In this
protocol, the participants were to generate three to four agent pairs, then the
participants would read each agent-patient pair aloud (the verb was not read
aloud) and then chose one answer to a wh-question. During treatment,
participants were asked to produce orally three to four thematic role pairs
(e.g. carpenter and lumber) for a provided verb (e.g. measure). When they
were unable to produce a word, written options on cards were provided (some
appropriate and some foils). Participants were encouraged to provide at least
one personal pair (e.g., dad/boat for drive), and responses could change from
week to week. In the original protocol (i.e., Edmonds et al., 2009), after
generating three to four appropriate agent-patient pairs, participants read
each agent-patient pair aloud (the verb was not read aloud) and chose one to
answer wh-questions about it (e.g. when, where, or why). Following the
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protocol, when the participants were unable to produce thematic role pairs for
a provided verb; they were allowed to write their responses. Criterion for
ending treatment is met when participants produced a minimum of 24 relevant
agent-patient pairs (80% accuracy) during treatment Step 1 (e.g., for
measure, acceptable pairs could include chef/sugar, wife/windows, or
designer/room).
Treatment session structure for VNeST
During administration, probe pictures were presented pseudorandomly
with semantically related verbs (e.g.bake/fry) in non-sequential order. For
each picture, participants were instructed to make a sentence and include
him/her, the action, and this (while pointing to the agent [carpenter], verb
[measure], and patient [stairs]). Prompts were not provided unless the
participant produced a general word for the target (e.g. cut instead of slice or
man instead of carpenter), for which a prompt for a more specific word was
given. The VNeST data per participant can be found in figures 2. & 3.
Post-Treatment Testing
The measures assessed during initial testing were repeated during the
post-treatment session immediately following the cessation of treatment.
Tests results were analyzed from pre-to post treatment to address single
lexical retrieval using the Western Aphasia Battery-Revised (WAB-R), the
Boston Naming Test, (BNT; Kaplan, Goodglass & Weintraub,1983), the
Northwestern Assessment of Verbs and Sentences (NAVS) (Thompson,
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2002). Finally, to gauge lexical retrieval in connected speech were evaluated
with 10 elicitation materials from Nicholas and Brookshire (1993).
The participants underwent post-treatment testing to 1) To determine
treatment gains in rate of speech or words per minute, subject-verb-object
production or sentence level production and error rate or discourse, 2)
Assessment generalization of untrained verbs in VNeST. 3) Assess changes
in their Aphasia Quotient on the (WAB-R). Additionally, a four-week posttreatment session was conducted to evaluate the maintenance of treatment
gains in production of scripts and naming of trained subject, verb, and objects
combinations in VNeST.
Table 4.
Post-Treatment Assessment Scores
WAB-R

P1

69.9

BNT

NAVS

N =60

N=22

44

17

CIUS

CLQT

ABA-2

15

190
Attention,
165
Memory,
33
Executive
Functions,
22
Language
moderately
severe
score in
language,
98

Mild

48

Visuospatial
Skills

P2

50.3

34

10

12

193
Attention,
185
Memory,30
Executive
Functions,
20
Language
severe
score in
language,
89
Visuospatial
Skills

WNL

Treatment Fidelity
Treatment fidelity refers to the methodological strategies used to monitor
and enhance the reliability and validity of behavioral interventions (Robey,
2004). For script therapy, each participant was evaluated after each session on
the following: percentage of script related words, number of morphemes,
number of nouns, number of verbs, and number of modifiers. The VNeST data
included the percentage of verbs, percentage of objects, percentage of
subjects, the wh-questions, and semantic judgment.
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Figure 2. Script Therapy data for P1.
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Figure 5. VNeST Data for P2.
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Reliability
Reliability was determined for a number of measures by the author and
three trained research assistants. Reliability was determined by dividing the
number of responses agreed upon by the total number of responses scored.
Pre-to-post-treatment language measures. Inter-rater reliability was
conducted on pre-to-post treatment language measure. A reliability score of
(0.97) was attained on all pre- and post- treatment measures. Scoring
agreement was (0.92).
Treatment. Three trained master’s level research assistants watched
55% of all sessions to ensure adherence to treatment protocol. Inter-rater
reliability scores were calculated for each of the variables. Approximately,
60% of the probes from baseline, treatment, and maintenance phases were
rescored by the three research assistants. Prior to the initiation of the study,
the three research assistants were trained on Script and VNeST treatment
protocols. The research assistants were also trained on the Systematic
Analysis of Language Transcriptions (SALT; Miller & Iglesias, 2012). Using
the Pearson Correlation Coefficient, agreement in responses, and scoring
among three research assistants was (.94) on all post- testing measures.
Treatment Reliability for Script. Pre-, Post- and maintenance Scripts
were audiotaped and transcribed and compared with target Scripts for
content, grammatical productivity, and rate of Script words produced. All
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Scripts were transcribed by the primary investigator and one of the three
master’s level research assistants. Inter-rater reliability of all script therapy
sessions were rescored and transcribed independently by the three masters
level research assistants which the score was (.93) using a Pearson Product
Correlation Coefficient on all script variables.
Treatment Reliability for VNeST. To ensure the VNeST treatment
protocol was conducted consistently, the same three master level research
assistants participated in 55% of all sessions. Treatment reliability was
followed approximately (.95) using a Pearson Product Correlation Coefficient
with the VNeST protocol. For inter-rater reliability, all VNeST sessions were
rescored and transcribed independently by the three masters level research
assistants which the agreement score in responses and scoring among two
research assistants was (.91) on all VNeST variables.
Measures
Probe measures
The probes measures consisted of short language samples including
picture sequences/descriptions, short novel videos, and procedural
narratives. All probes were randomly assigned during the second session of
each week. For all probes a series of prompts were offered to help elicit more
language. For each probe, participants were instructed to “make a sentence
and include what he or she is doing in each picture, or tell me what is
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happening, and please tell me more, tell me the steps involved in. A
randomized list of six prompts for each probe were used throughout this
study.
Pre-, mid-, and post- treatment probes. Both participants were
measured at pre- and post- treatment using picture narrative tasks from the
Nicholas and Brookshire Picture cards. The Cookie Theft Picture from the
Boston Diagnostic Aphasia Examination (BDAE; Goodglass & Kaplan, 1972)
was used to assess the mid-treatment probe.
Pre-to-Post Treatment Measures (Dependent Variables)
The dependent variables include rate of speech, subject- verb-object
production (SVO), and error rate. Rate of speech was determined by words
per minute. Addtionally, rate of speech is an example of a word level
measure. Subject -verb- object (SVO) production was based on all sentences
that contained the correct S-V-O structure (not including grammatical
correctness- use of functor words). S-V-O production is an example of a
sentence level measure. Error rates are an example of a discourse level
measure. For error rates, this was determined by the number of paraphasias,
(phonemic/semantic), repetitions, omissions, substitutions, I don't know
responses/no responses, incomplete utterances, morphological errors,
interjections (um), and perseverations. All outcome measures were assessed
over a two-minute time period during probe tasks. The probe tasks consisted
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of a short video that was viewed on an Ipad approximately two minutes in
length, a picture sequence (3-4 pictures), or procedural narratives.
The Independent variables included the two treatments of Script
therapy and VNeST. The generalization of these variables was measured on
the three dependent variables during the second session of each week.
Risks and Benefits
Participating in the study did not put the participants at any potential
risk or discomfort. Participation did benefit the participants directly.
Participation was completely voluntary and the participants had the choice to
stop and withdraw from the study at any time.
Ethical Considerations
The principle investigator and three master’s level research assistants
were the only individuals to have access to the participant videos and
transcripts throughout the study and data collection.
Equipment/Instruments: Video/Audio Taping
All participant data were collected in the LaSalle University SpeechLanguage-Hearing Community Clinics. Video and audio taping was collected
using the Logitech Webcam software were used to record both video and
audio sample of clients. An additional Sony Digital Voice recorder (ICDBM1VTP) were used to record all samples during sessions. The data was
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collected via digital video and audio recorder at the beginning of each session
and later transcribed. All videos, audio recordings, and transcribed samples
were kept on a password protected external hard drive in a locked office. All
collected data will be kept for at least 3 years after project completion. All
participants were de-identified after they consent to the study by an alphanumeric code will be used in place of their names. The informed consent form
will be the only place where their name appears and these will be locked in a
file cabinet in an office to ensure no connection can be made between the
subject and all data. After the participants consented to the study, they were
assigned an alpha numeric code which was placed on all materials instead of
their name. All data will be kept in locked in a file cabinet in which is password
protected. The keys for the file cabinet were also under lock and key. All
electronic video/audio tapes were stored on an external hard drive which was
locked in a cabinet in the primary investigator’s office.
Statistical Analysis
In this study, both dependent and independent variables were
analyzed using SPSS statistic software version 24.
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Chapter IV

RESULTS

Study Objectives
The objectives of the current study were to determine which of the two
treatments: Script and/or VNeST were beneficial in the improvement of the
word, sentence, and discourse level measures.
Data Analyses
To answer the study predictions and research questions, the following
statistical methods were used. The first analysis included the variability on the
pre- and post-treatment scores from baseline to maintenance. Secondly, each
of the three outcome measures: (rate of speech, SVO, and error rate) were
analyzed from the baseline to maintenance stages to determine improvement.
Third, using the Busk and Serlin’s (1992) d2 effect size formula, the outcome
measures were evaluated according to the magnitude of change from
baseline to maintenance tasks. Lastly, using the Percentage of Data
Exceeding the Median Scores (PEM), both participants were evaluated for the
effectiveness of the interventions.
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Each research question and hypothesis is reiterated below, followed by the
results for each question.
1.) RQ1. Does the combination of Script and VNeST interventions
improve language outcomes in individuals with chronic agrammatic
Broca’s aphasia during standardized assessment measures?
H1a. Participants will increase language skills including naming,
comprehension, narrative production and cognitive skill areas from pretreatment to post-treatment.
2.) RQ2. Do the participants show gains in word level, sentence level,
and discourse level measures obtained from baseline to maintenance
phases?
H2a. Participants will show gains in rate of speech, SVO production,
and decrease error rates obtained from language samples at baseline
through maintenance phases.
3.) RQ3. What are the relative effects across interventions on word,
sentence, and discourse level measures obtained from language
samples?
H3. Large effect sizes will be found on word, sentence, and discourse
level measures across interventions.
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3a.) RQ3a. What are the relative effects for each participant on
word, sentence, and discourse level measures across interventions?
H3a Large effect sizes will be found on word, sentence, and
discourse level measures for each intervention per participant

4.) RQ4. How does Script compare to VNeST intervention for improving
language outcomes in individuals with chronic agrammatic Broca’s
aphasia?
H4a. VneST will be more efficient in improving language outcomes for
the chronic agrammatic population.
Analysis of RQ1. When analyzing the standardized assessment data,
a percentage of change score was obtained. To evaluate standardized
assessment data, both participants increased on the subtest of the WAB-R
scores including auditory comprehension, fluency, repetition, and naming.
P1’s aphasia quotient increased from 46.5 to 69.9. P2’s aphasia quotient
increased from 42.5 to 50.3. On the BNT, P1’s scores increased from 31 to
44 and P2’s score increased from 30 to 34. Additionally, both participants
increased on the confrontation naming task of the BNT scores, and the
executive functioning scores on the CLQT. P1 increased her NAVS scores
from 45% to 57%. P2’s pre- and post- NAVS score remained the same. On
the NAVS, P2 had more difficulty with the verb production task and the
argument structure task indicating that production of verbs was more difficult
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for this participant. P1 was able to slightly increase her CIUS with the
procedural narrative tasks increasing from 4 to 5 words and her percentage of
CIUS increased from 10 to 11 on the picture description tasks. Furthermore,
P2 did not increase his CIUs production on picture sequencing tasks from
pre- to post- treatment. Both participants were able to increase their language
subtest scores on the CLQT language scores 15 to 22 and 11 to 20. Please
see Table 5 for full assessment data scores.
Table. 5
Descriptive Statistics for Pre- and Post- Treatment Assessment Data.
P1

P2

Pre

Post

Pre

Post

WAB-R

46.5

69.9

42.5

50.3

BNT

31

44

30

34

NAVS

45%

57%

38%

38%

CIUS

4,10,4

5,11,5

3,9,4

4,10,4

CLQT

15

22

11

20
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Figure 6. Rate of speech for P1 and P2 from baseline through maintenance
phases.
P1 rate of speech increased from 19 to 40 (WPM; words per minute)
from baseline to maintenance phases. P1 demonstrated an upward trend
throughout the study, except during the washout period. She received Script
therapy and then VNeST interventions. P2 received VNeST and then Script
interventions. P2’s rate of speech increased from 11 to 31 WPM from
baseline to maintenance phases. Also, P2 exhibited a decrease in rate or
WPM during the washout period as P1. Overall, P2’s rate of speech did
increase but not as significantly as P1’s rate.
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Figure 7. Sentence-Verb-Object (SVO) production per participant across
baseline to maintenance phases
Both participants increased SVO production from baseline to
maintenance phases. During the washout period, both participant exhibited
the same decline in SVO production as with rate of speech. P1’s SVO
production increased from 3 to 9 SVO productions from baseline to
maintenance phases. P2’s increased from 4 to 5 SVO productions from
baseline to maintenance phases. Similarly, P2’s SVO production did increase
but not as much as P1’s. Also, with the rate of speech measure, SVO
production also decreased with both participants during the no-intervention
phase.
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Figure 8. Percentage of error per participant from baseline to maintenance
phases.
Error rates for both participants remained high throughout the study.
P1’s error rate decreased from 46% to 21% from baseline to maintenance.
P2’s error rate increased from 39% to 52% from baseline to maintenance.
Both participants’ error rates were the highest during the no intervention
phase.
Analysis of RQ2. Given the order of treatments, both participants
increased their word level measures or rate of speech, SVO or sentence level
measures and P1’s error rate or discourse level measure decreased from the
baseline to maintenance phases. These results indicate that both
interventions were effective for P1 and P2 at the word and sentence level. As
for error rate, only P1’s error rate decreased from pre-to-post treatment. For
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P2, his error rate increased from baseline to maintenance phases. The
effectiveness of these treatments can be seen during the no intervention
phase where all outcomes either decreased or increased for these
participants. In summary, during the intervention phases both participants
benefitted from these treatments.
Analysis of RQ3. To evaluate RQ3. (magnitude of change from
baseline to maintenance), effect sizes (d2; Busk & Serlin, 1992), were
calculated to get to get an “index of durability” (Beeson & Robey, 2006,
p.167). A meta-analysis of aphasic treatment studies by Robey and Beeson
(2006) resulted in benchmarks of 4.0, 7.0, and 10.1 for small, medium, and
large effects so these numbers are used to aid interpretation of the results.
Table 6.
Effect sizes from baseline to maintenance phases

Rate of Speech

SVO Production

P1

P2

40-21/3.93)= 4.83

(26.67-12.33/3.36)=4.27

Small effect

Small effect

(8.66-3.66/0.57)=8.77

(4.33-3/1.07)=1.24

Medium to large effect

Relatively no effect
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Error Rate

(25-40/4.44)=3.37

(51-37/3.02)=4.63

Relatively no effect

Small effect

Busk and Serlin
d2=x−A2−x−A1
spooled
Figure 9. Busk & Serlin’s (1992) Equation for calculations of effect sizes.
Beeson and Robey (2006) explained that Busk and Serlin’s d2 (1992)
effect size formula is beneficial in single subject designs such as this study.
Busks and Serlins’ (1992) formula states that A2 and A1 designates
maintenance and pre-treatment periods, respectively, x̄ A is the mean of the
data collected in a period, and spooled is the square root of the weighted
average of the variances for A1 and A2.
According to the Beeson and Robey (2006) benchmarks, the effect
sizes for rate of speech or word level measures were (d2 = 4.83; d2 = 4.27
WPM) indicating a small effect for WPM for both participants. For SVO
production or sentence level measures, P1 yielded an effect size of (d2 =
8.75) indicating a medium to large effect. P1 increased her SVO combinations
from 4 to 9 by the maintenance phase. P2’s SVO production yielded little to
no effect (d2 = 1.02). For error rates, the effect sizes were calculated using
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absolute value since the two treatments were designed to decrease an
undesirable behavior rather than increase a desirable behavior (Beeson &
Robey, 2006).
On discourse level measures, P1’s error rate yielded little to no effect
(d2 = 3.37). This effect size for error rate was interesting in the fact that P1’s
error rate did decline from the baseline to maintenance phases. Furthermore,
P2’s error rate yielded a small effect (d2 = 4.63) indicating that error rates did
increase by 5 errors per probe from baseline to maintenance phases.
Analysis of RQ3a. Using the Percentage of Data Points Exceeding
the Median (PEM) scores, Ma (2006) created another way to evaluate data
interventions. For intervention studies focusing on increasing behaviors, Ma
(2006) suggested that reviewers draw a median line for the baseline data and
calculate the percentage of data points in intervention that fall above the
median line for behavior reduction studies, then percentage of data points
below the median line should be calculated. Several strengths could be found
in the PEM approach. First, there have been no reports of situations where
PEM could not be used. Second, PEM has been shown to be correlated with
author judgments of intervention effectiveness (Ma, 2006). The null
hypothesis of the PEM approach is that if the treatment has no effect, the
data points in the treatment phase will fluctuate up and down around the
middle line. The data points have 50% of chance of being above and 50%
chance of being below the median of previous baseline phase. The PEM
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score has a range of 0 to 1. The PEM score has the same meaning as the
effect size. One can compute one PEM score from each pair of baseline
treatment phases. One can further calculate the overall mean effect size of
each article or the mean effect size of each variable category.
Table 7.
Score Ranges for PEM interventions.
PEM Score Ranges
.9 to 1

Highly Effective Treatment

.7 to .9

Moderately Effective Treatment

< .7

Questionable or Ineffective Treatment

Number of Words Per Minute

60

PEM= 9/9=1

PEM= 7/9= .78

50

52

50

47

45

44

41

40
36

20

33

31

30

27
19

35

55
49

52

38

41 41

31

27

25
18 18

17

10

10
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0

0
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PEM for Rate of Speech for P1 during Script and VNeST
Figure 10. PEM data for P1 for Rate of Speech during Script and VNeST.
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P1’s PEM score for rate of speech yielded a score of 19 words per
minute at baseline which means that Script Therapy (PEM score = .78) which
indicates that Script was moderately effective. A PEM score of (1) on VNeST

Number of SVO productions

indicates that this therapy was highly effective for this participant.
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Figure 11. PEM data for P1 for SVO production during both Script and VNeST
For P1, Script therapy (PEM = .78) was moderately effective in the first
nine weeks on the SVO outcome measure. Additionally, P1’s score of (PEM =
1) during VNeST therapy means that this therapy was highly effective.
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Figure 12. PEM data for P1 for Error Rate during both Script and VNeST
P1’s PEM scores were (.67) for Script indicating a questionable effect
and (.78) VNeST interventions indicating moderately effective on the outcome
measure of error rate.
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Figure 13. PEM data for P2 for rate of speech during VNeST and Script
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For both VNeST and Script treatments, P2 exhibited PEM scores of (1

Number of SVO productions

& 1) indicating that both treatments were highly effective on rate of speech.

PEM= 9/9 = 1

PEM= 4/9= .44
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PEM for P2 for SVO production during VNeST and
Script
Figure 14. PEM data for P2 for SVO production during VNeST and Script
For VNeST, P2’s PEM score was (.44) indicating that this treatment
was ineffective. For Script therapy, P2’s PEM score (1) indicated that Script
therapy was highly effective.
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Figure 15. PEM data for P2 for Error Rate during VNeST and Script
P2’s PEM score was (.11) on VNeST and (.44) on Scripts indicated
that neither treatment was effective for error rate.
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Table 8.
Summary Table for Effect Sizes and PEM Scores for P1

P1
Script

VNeST

PEM

PEM

Rate of
Speech

.78
Moderately effective

1
Highly effective

Baseline to
Maintenance
Effects
4.83
Small effect

SVO

.78
Moderately effective
.67
Ineffective

1
Highly effective
.78
Moderate effect

8.77
Medium to large effect
3.37
No effect

Error rate

Table 9.
Summary table for effect sizes and PEM scores for P2

P2
VNeST

Script

PEM

PEM

Rate of
Speech

1
Highly effective

1
Highly effective

Baseline to
Maintenance
Effects
4.27
Small effect

SVO

.44
Ineffective

1
Highly effective

1.24
No effect

Error rate

.11
Ineffective

.44
Ineffective

4.63
Small effect

72

Summary analysis (RQ4.) When analyzing the baseline to
maintenance effects, and PEM scores, both participants demonstrated
variability on outcome measures across interventions. P1 exhibited a small
effect for Script therapy on the outcomes measures. For VNeST, P1
demonstrated a greater change for SVO production. After analyzing baseline
to maintenance effects, P1 demonstrated small effects for rate of speech and
medium to large effects or change for SVO. P1 produced more limited effects
during both interventions. The PEM scores for VNest do prove this
intervention was beneficial for P2. A small effect was noted for rate of speech
during Script therapy. PEM scores did show that Script therapy was effective
for rate of speech and SVO for P2 .For baseline to maintenance effects, a
small effect was noted for rate of speech and error rates. P2’s error rate did
change but actually increased from baseline to maintenance probes.
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Chapter V

DISCUSSION

The aim of this study was to assess whether one treatment: Script or
VNeST was more beneficial for participants with agrammatic Broca’s aphasia
and to determine the effects on outcome measures at the word, sentence,
and discourse levels. Also, to determine whether a combination of the social
functional and impairment specific approaches are most effective for this
population and to explore the use of a single subject multiple-baseline
alternating treatment across participants’ design.
Study Predictions
It was predicted that the participants would demonstrate an increase
in rate of speech and SVO production through the study. Another prediction
was that error rates would decrease over the course of both treatments.
Overall Results of Interventions
Both participants benefitted from the interventions in this study even
though they were considerably post-incident at 20 and 26 months. The
participants made considerable gains on the outcome variables.
Validity of standardized assessment measures
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Pre- and post-treatment and descriptive data demonstrated that the
participants were similar across demographic and assessment scores. The
overall results showed different responses across participants with P1
exhibiting greater effects than P2. The results of the pre-and post-treatment
measures were similar to previous studies have established that traditional
linguistic or impairment specific approaches have an effect on impairment
measures such as the WAB-R, NAVS, CLQT, CIUS and BNT (Edmonds et
al., 2009, Edmonds & Babb, 2011, Beeson & Robey, 2006). Both participants
with agrammatic Broca’s aphasia benefitted from the two treatment
approaches based on post-treatment assessment scores. Based on the posttreatment results, these assessments are useful for validating the
interventions as well as providing quality linguistic and cognitive data for
individuals with agrammatic Broca’s aphasia. Furthermore, examining the
effect sizes can help determine if the interventions were beneficial and PEM
data can show the variability of both interventions per participant.
Effect Sizes
Baseline to Maintenance Effects
For rate of speech, P1 and P2 yielded small effect sizes (P1: d2 =
4.83; P2: d2 = 4.27) based on baseline to maintenance phases. For SVO
production, P1 produced a medium to large effect (P1: d2 = 8.75). P2
demonstrated relatively no effect for SVO production with a small effect (P2:
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d2= 1.02). For error rate, P1 produced relatively no effect of (P1: d2 = 3.37).
P2 produced a smaller unfavorable effect for error rate (P2: d2 = 4.63).
After analyzing the effect size outcomes, it is important to note that the
Beeson and Robey benchmarks (4.0,7.0, and 10.1) are set as framework for
aphasia research. Additionally, these effect size values provide a means to
compare treatment outcomes within and between individuals, as well as to
compare the relative strength of various treatments for aphasic populations
(Beeson & Robey, 2006).
In this study, the participants did demonstrate improvements, despite
small effect sizes indicating that these therapies were useful in producing
change for the agrammatic Broca’s aphasia.
Percentage of Data Exceeding the Median (PEM)
In general, the effect sizes were not always consistent with the PEM
results per participant. The PEM scores can help validate effective
interventions and can contribute to the strength of the effect size scores (Ma,
2006). It is important to note that PEM evaluates a potential change or
variation of scores across treatment and probe assessment sessions. P1’s
PEM score for rate of speech during Script was moderately effective. For
VNeST, P1’S PEM score was highly effective. P2’s PEM rate of speech score
was very effective for both treatments. For P1, Script therapy PEM score was
moderately effective in the first nine week SVO production. P1’s VNeST PEM
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score was very effective for SVO production. For P2, SVO PEM score was
moderately effective for VNeST and highly effective for Script. For error rate,
P1’S PEM score was ineffective with script and moderately effective for
VNeST. P2’s PEM score for error rate for both interventions were scored as
ineffective.
Effectiveness of the Interventions by outcome measure
Based on the effect sizes and inter-therapeutic PEM scores, both
interventions Script and VNeST were found effective in treating at the word
and sentence levels for these participants with chronic agrammatic Broca’s
aphasia. VNeST was considered more effective for both participants for rate
of speech based on PEM scores. Script was considered most effective for
SVO productions based on inter-therapeutic PEM scores. Finally, neither
intervention was considered effective for error rate. For P1, VNeST was more
effective than Script during the therapeutic phase of study on all outcome
measures. Script Therapy was more effective on rate of speech and SVO
production during the therapeutic phase of the study for P2.
Given the participants status post stroke, perhaps they have to live
with some errors in speech at the sacrifice of clearer communication. In the
future, it may be possible to isolate the error patterns and provide an
alternative type of therapy that would address specific errors per participant.
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Effectiveness of the Interventions per participant
After summarizing the effect sizes, and PEM scores, it appears that
both treatments were successful for P1 and P2 performance in individual
ways. VNeST involves the activation of large semantic networks that can
potentially result in generalization to lexical retrieval. (Edmonds et al., 2009).
Theoretically, generalization to outcome measures should occur if other, more
complex measures are also to improve. This appears to be the case for P1,
she improved over the course of the 18 weeks with the outcome measures;
however, her error rate decreased with no effect. For P1, she demonstrated
generalization on the outcome measure of rate of speech across the course
of the 18 weeks. Additionally, she increased on all pre-to-post treatment
assessment measures. She presented with morphological errors, repetition
errors, and articulation errors due to apraxia, but her word retrieval was better
for semantic networking. P1 was rated as mildy apraxic so having phonemic
errors are consistent her diagnosis of agrammatic Broca’s aphasia and
apraxia. Additionally, P1 did suffer seizures after the stroke with which she
was currently being medicated and the impact of the medication Gabapentin
may have impacted her performance during the study.
Although, P2 presented with more limited generalization on outcome
measures, there were many indications for clinical improvements. First, he
increased his pre-to-post treatment assessments scores except for the NAVs
and CIUs. It is not completely clear as to why P2 did not improve to the extent
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that P1 did throughout the study. Both participants did improve over the
course of the study but P1’s effect sizes from baseline to maintenance
demonstrated a greater magnitude of change. First, it is possible that the time
between P2’s stroke and the start of the study could have attributed to the
second participants level of performance. Secondly, P2 had slightly lower
scores on the assessments than P1. P2 presented with slightly lower scores
on the comprehension portions of the WAB-R, CLQT (Auditory
Comprehension portion), and the NAVS (verb comprehension subtest). P2’s
processing and retrieval speed was also more reduced than P1. Furthermore,
P2 presented with a dysarthric speech pattern that was different than P1. In
P2’s case history, he was diagnosed with depression after his stroke and was
being treated with Zoloft an anti-depressant medication. Both participants had
a similar cognitive profile for the CLQT. However, in-depth testing for
cognition including working memory, attention, and other executive
functioning abilities was not assessed during this study and could affect the
response to treatment. P2 was more chronic in terms of word retrieval and
types of errors. P2’s wife said he was more willing to attempt SVO phrases at
home with prompting than prior to the study. P2’s errors included phonemic
and semantic paraphasias, morphological errors, and perservations.
Despite differences in generalization across participants and
interventions, both participants’ post-treatment error patterns showed an
evolution of responses that suggest differences in processing and lexical
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retrieval during interventions. Across the tasks, P1 made more attempts at
production and her post-treatment errors were more motor planning errors
consistent with the apraxia diagnosis. For P2, presented more with lexical
retrieval errors.
Other factors that can also contribute to the generalization across
participants and the interventions include the intensity of the treatments, the
impact of impairment specific and social functional approaches,
communicative intent, differences in gender, and the order of interventions.
Intensity of therapy
In accordance with the pre-and post-treatment scores, the intensity of
the therapies and the length of the study (two times per week for 18 weeks)
could be another factor in the overall improvements on the treatment effects
and outcome measures. Both Script and VNeST treatment protocols are
based on nine weeks of treatment with two-one hour sessions per week
(Cherney, 2010; Cherney et al., 2008; Cherney et al., 2011, Edmonds &
Babb, 2011; Edmonds et al., 2014). This study’s treatment was consistent
with Robey’s (1998) meta-analysis which demonstrated that the minimum
intensity of aphasia therapy that affected change equaled two hours per week
for chronic aphasics.
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Impairment Specific vs. Social Functional
Given the fact that Script therapy is a social functional approach and
that VNeST is an impairment specific approach, it is seemed counterintuitive
that P1 and P2 exhibited such widespread gains. There are a number of
factors that would predict potential improvements with this population. First,
VNeST allows for the training of verbs, subjects, and objects which is the
foundation needed for sentence production (Edmonds, et al., 2009; Edmonds
& Babb, 2011). Second, VNeST is a semantic treatment that focuses on
lexical, semantic, and phonological activation so theoretically during all
phases of VNeST each area is activated (Edmonds et al., 2009). Nickels
(2002) explained that individuals with impaired phonological, semantic, and
lexical levels seem to benefit from tasks that combine semantic networking
and activation. Additional areas such as the communicative intent, gender
differences and the order of the interventions all can contribute to the
effectiveness.
Communicative Intent
Unlike VNeST, Script Therapy focuses on retraining phrases of fluent
automatic speech. This promotes personal functional sentence production for
individuals with aphasia and apraxia of speech. Script therapy focuses on a
social approach to communication. Additionally, the use of Scripts allowed
these participants to tailor their intentions for communication. P1’s intention
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for communication involved being able to have a repertoire of phrases that
she could use with her daughter’s pre-school teacher. For P2, he wanted to
be able to have a phone conversation with long-distance family members.
Gender Differences
Males have a higher significance of morbidity for aphasia than females
(69.90% to females 42.97%) especially after stroke (Yao et al., 2015). Broca’s
aphasia was reported as the most common type of aphasia for both male and
female (29.01% and 24.22%). For the participants in this study, it was
conclusive that the male participant exhibited greater impairment in
communication than the female participant which was consistent with
previous research findings.
Order of Interventions
Based on the data for P2, this participant benefitted from receiving
VNeST therapy first and then Script Therapy. For this participant, the VNeST
treatment acted as a priming effect for this participant. A similar result was
found in Edmonds and Babb (2012). P1 improved on all dependent variables
from Script Therapy to VNeST therapy. It seems that P1 benefitted from both
intensity of therapy and the Script treatment then VNeST. It was hypothesized
that P1 had more predicted motor planning issues due to the apraxia than
word retrieval deficits. For P2, it seemed that VNeST helped with the
activation of the semantic, phonological, and lexical retrieval which helped
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possibly with the activation of the executive function areas such as memory,
initiation, and recall (Fridrickson, Nettles, Davis, Morrow & Montgomery,
2006).
Effectiveness of study design
The use of the multiple baseline single subject alternating treatment
across participants’ design offered the ability to look at the individual
variability with the outcome measures, error types, and account for individual
variances. It was predicted that single subject designs are less concerned
with trends and help to increase internal validity and generalizability to real
world clinical applications for specific populations like agrammatic Broca’s
aphasia (Schwartz, 2010; Olswang, 1993; Beeson & Robey, 2006).
Additionally, effectiveness studies or treatment outcome research can
evaluate the effects of efficacious treatments across broader, more typical
populations and under broader, more typical clinical conditions (Olswang,
1993). These designs foster treatment outcome changes during or after the
treatment process and addresses a variety of questions including cost of
treatment, quality of care, and achievement of functional change in the client
(Olswang, 1993).
Clinical Implications
Clinical Feasibility

83

Based on the outcomes of this study, both treatments can potentially
benefit the agrammatic Broca’s aphasic population. Both treatments, Script
and VNeST, can be easily administered by speech-language pathologists,
they are cost effective and have a high treatment intensity that is necessary
for chronic aphasics. Additionally, the use of an impairment specific treatment
in combination with a social functional treatment can better target the
agrammatic Broca’s aphasics ability to access fluent and accurate language
and can have tangible and psychosocial benefits.
Limitations
Although the present study has yielded some preliminary findings,
there were some limitations. These limitations included possible treatment
effects of the 18-week treatment. Treatment fatigue due to the longevity of the
study. There were a limited number of participants recruited due to the type of
aphasia and the length of the study. Statistical challenges included the small
number of participants, the use of non-parametric statistics, and possible
order effects on outcome measures. In the data analysis, there was limited
ability to generalize results due to the small sample size and the convenience
of the sample. Furthermore, the findings of the study can be generalized to
the population of agrammatic Broca’s aphasia. Nevertheless, aphasia is a
multifaceted condition with each individual presenting with different symptoms
and levels of severity.
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Chapter VI

CONCLUSIONS

This chapter highlights the results of the current study and the
conclusions drawn regarding the outcome measures and the treatment
approaches. Moreover, the need for future research is outlined.
Conclusion
Severity of aphasia and individual participants' characteristics impact
the relationship between intensity and improvement (Lee et al., 2009). P2 had
a different intention to communicate than P1. People with aphasia choose to
speak about their life experiences, choose to reconnect with their families,
and tend to focus on communication that can help them to negotiate
mundane normal life. Independent of how this content is used in treatment,
materials should emphasize matters of high personal relevance to those
treated (Holland, Halper & Cherney, 2010).
It is possible that the multi-modal nature of the training between
VNeST and Script helps promote functional sentence production and a
linguistic approach for sentence production contributed to a positive language
change for both participants (Edmonds, Nadeau,& Kiran, 2009; Edmonds &
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Babb, 2011, Edmonds, Mammino, & Ojeda, 2014; Cherney, Halper, Holland,
& Cole, 2008).
P2 did exhibit difficultly initiating language more so than P1. It seemed
beneficial for this participant to have a scripted inventory of phrases that he
could use.
P2 had an easier time finding the correct words, but would often have
difficulty and either perseverate or produce phonemic paraphasias. P1
presented with more anomic responses so she often said she didn’t know or
produced repetitious responses.
Future Directions
This study is a contribution to clinical practice in aphasia. Results such
as those in the present study will hopefully advance the knowledge on
treatment options and serve as a basis for applying an impairment specific
treatment and social functional treatment for individuals with agrammatic
Broca’s aphasia. This study also demonstrated the benefits of using a
multiple- baseline across participants design with this population from a cost
and benefit perspective. Also, the two treatments in this study can help
speech-language pathologists help deliver beneficial, cost effective, and
feasible care to their patients.
Future areas of research could involve more participants, possibly
implementing VNeST first for the first treatment and then alternating with
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another social functional approach like Script or a Supported Conversation
Treatment.
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APPENDIX B

HACKENSACK UNIVERSITY MEDICAL CENTER IRB APPROVAL

NOTIFICATION OF APPROVED EXPEDITED CONTINUING REVIEW

From:

Robert Krugman, MD

To:

Maureen Costello-Yacono

CC:
Continuing Review # CR00003707 for Study#: Pro00006239
Re:

Study Title: 2017 Review for Pro00006239 - Comparison of Two
Treatment Approaches for Agrammatic Aphasia
Expiration Date: 4/26/2018

This is to advise you that the above referenced Study has been presented to the
Institutional Review Board for Expedited Review.
Please be reminded that all modifications to approved projects must be reviewed
and approved by the Institutional Review Board before they may be implemented.
Any changes to this protocol must be submitted for IRB approval before initiated.
All Serious adverse events and unexpected adverse events must be reported to
Institutional Review Board within seven days.
Please do not make any changes to the IRB approved consent without approval of
the IRB. Only the IRB stamped approved consent should be used.
If your study meets the definition of a qualifying study that meets the FDAAA 801
definition of an "applicable clinical trial", you are responsible for ensuring that the trial has
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been registered properly on the Clinical Trials.gov website prior to the enrollment of any
subject.
"Applicable clinical trials" generally include controlled clinical investigations, other than
phase 1 clinical investigations (with one or more arms) of FDA-regulated drugs, biological
products, or devices, that meet one of the following conditions:
•
The trial has one or more sites in the United States
•
The trial is conducted under an FDA investigational new drug application or
investigational device exemption
•
The trial involves a drug, biologic, or device that is manufactured in the United
States or its territories and is exported for research
For complete statutory definitions and more information on the meaning of "applicable
clinical trial," see Elaboration of Definitions of Responsible Party and Applicable Clinical
Trial (PDF).

It is necessary that you utilize the assigned protocol number in any and all
communication submitted to the IRB office, i.e. amendments, audits, etc.

This renewal has been approved via expedited review on 4/27/2017.

Important news about our email communications.
Hackensack Meridian Health Network has implemented secure messaging services. If you need assistance
with retrieving a secure email, please send an e-mail to

postmaster@hackensackmeridian.org

Confidentiality Notice:
This e-mail message and any attachments from Hackensack University Medical Center are confidential and for the sole use of the
intended recipient. This communication may contain Protected Health Information ("PHI"). PHI is confidential information that may only
be used or disclosed in accordance with applicable law. There are penalties under the law for the improper use or further disclosure of
PHI. If you are not the intended recipient of this e-mail or the employee or agent responsible for delivering the communication to the
intended recipient, then you may not read, copy, distribute or otherwise use or disclose the information contained in this message. If you
received this message in error, please notify us by telephone at 551.996.2000 or by e-mail to postmaster@hackensackmeridian.org.
Please indicate that you were not the intended recipient, and confirm that you have deleted the original message. Please do not retransmit
the contents of the message. Thank you. Hackensack Meridian Health Network is the proud recipient of Quality New Jersey's Governor's
Gold Award for Performance Excellence
Hackensack Meridian Health Network
30 Prospect Avenue Hackensack, New Jersey 07601 551-996-2000
Copyright © 2016 Hackensack Meridian Health Network
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INFORMED CONSENT
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APPENDIX D

LETTER OF SOLICITATION
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APPENDIX E

INTERVENTION TABLES

Baseline outcome
measure assessment
Week 1; Session1
Week 1;
Session 2
Week 2; Session 1
Week2:
Session 2
Week 3; Session 1
Week 3; Session 2

Week 4;
Session 1
Week 4; Session 2

Week 5;
Session 1
Week 5; Session 2

Week 6:
Session 1
Week 6;
Session 2

P1
Randomized
probe/outcome
measures
Scripts Development
Script Development
Treatment of Scripts
(60 minutes)
Treatment of Scripts
Probe/Outcome
measure assessment
Treatment of Scripts
(60 minutes)
Treatment of Scripts
(60 minutes)
Probe/Outcome
measure assessment
Treatment of Scripts
(60 minutes)
Treatment of Scripts
(60 minutes)
Probe/Outcome
measure assessment
Treatment of Scripts
(60 minutes)
P1
Treatment of Scripts
(60 minutes)
Probe/Outcome
measure assessment
Treatment of Scripts
(60 minutes)
Treatment of Scripts
(60 minutes)
Probe/Outcome
measure assessment

P2
Randomized probe/outcome measures

VNeST Stimuli Development
VNeST
Stimuli Development
Treatment of Trained Verbs (60 minutes)
Treatment of Trained Verbs (60 minutes)
Probe/Outcome measure assessment
Treatment of Trained Verbs (60 minutes)
Treatment of Trained Verbs (60 minutes)
Probe/Outcome measure assessment

Treatment of Trained Verbs (60 minutes)
Treatment of Trained Verbs (60 minutes)
Probe/Outcome measure assessment

Treatment of Trained Verbs (60 minutes)
P2
Treatment of Trained Verbs (60 minutes)
Probe/Outcome measure assessment

Treatment of Trained Verbs (60 minutes)
Treatment of Trained Verbs (60 minutes)
Probe/Outcome measure assessment
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Week 7;
Session 1
Week 7;
Session 2

Treatment of Scripts
(60 minutes)
Treatment of Scripts
(60 minutes)
Probe/Outcome
measure assessment
Treatment of Scripts
(60 minutes)
Treatment of Scripts
(60 minutes)
Probe/Outcome
measure assessment
Treatment of Scripts
(60 minutes)
Treatment of Scripts
(60 minutes)
Probe/Outcome
measure assessment
Cookie Theft Pictures
to assess

Treatment of Trained Verbs (60 minutes)

PARTICIPANTS SWITCHED THERAPY

Week 10;
Session 1

PARTICIPANTS
SWITCHED THERAPY
VNEST Stimuli
Development

Week 10;
Session 2

VNEST Stimuli
Development

Script Development

Week 11;
Session 1

VNest
Stimuli Development

Script Development

Week 11;
Session 2;

Treatment of Trained
Verbs (60 minutes)
Probe/Outcome
measure assessment
Treatment of Trained
Verbs (60 minutes)

Treatment of Scripts (60 minutes)
Probe/Outcome measure assessment

Treatment of Trained
Verbs (60 minutes)
Probe/Outcome
measure assessment

Treatment of Scripts (60 minutes)
Probe/Outcome measure assessment

Week 8;
Session 1
Week 8;
Session 2

Week 9;
Session 1
Week 9;
Session 2

Session 9.5

Treatment of Trained Verbs (60 minutes)
Probe/Outcome measure assessment

Treatment of Trained Verbs (60 minutes)
Treatment of Trained Verbs (60 minutes)
Probe/Outcome measure assessment

Treatment of Trained Verbs (60 minutes)
Treatment of Trained Verbs (60 minutes)
Probe/Outcome measure assessment

Narrative story retell

Two week break
between treatments

Week 12; Session 1

Week 12; Session 2

Script Development

Treatment of Scripts (60 minutes)
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Week 13; Session 1

Treatment of Trained
Verbs (60 minutes)

Treatment of Scripts (60 minutes)

Week 13; Session 2

Treatment of Trained
Verbs (60 minutes)
Probe/Outcome
measure assessment
Treatment of Trained
Verbs (60 minutes)

Treatment of Scripts (60 minutes)
Probe/Outcome measure assessment

Treatment of Trained
Verbs (60 minutes)
Probe/Outcome
measure assessment
Treatment of Trained
Verbs (60 minutes)

Treatment of Scripts (60 minutes)
Probe/Outcome measure assessment

Week 15;
Session 2

Treatment of Trained
Verbs (60 minutes)
Probe/Outcome
measure assessment

Treatment of Scripts (60 minutes)
Probe/Outcome measure assessment

Week 16;
Session 1

Treatment of Trained
Verbs (60 minutes)

Treatment of Scripts (60 minutes)

Week 16; Session 2

Treatment of Trained
Verbs (60 minutes)
Probe/Outcome
measure assessment
Treatment of Trained
Verbs (60 minutes)

Treatment of Scripts (60 minutes)
Probe/Outcome measure assessment

Treatment of Trained
Verbs (60 minutes)
Probe/Outcome
measure assessment
Treatment of Trained
Verbs (60 minutes)

Treatment of Scripts (60 minutes)
Probe/Outcome measure assessment

Treatment of Trained
Verbs (60 minutes)
Probe/Outcome
measure assessment

Treatment of Scripts (60 minutes)
Probe/Outcome measure assessment

Week 14; Session 1

Week 14; Session 2

Week 15;
Session 1

Week 17; Session 1

Week 17; Session 2

Week 18; Session 1

Week 18; Session 2

Treatment of Scripts (60 minutes)

Treatment of Scripts (60 minutes)

Treatment of Scripts (60 minutes)

Treatment of Scripts (60 minutes)
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Post-Treatment
Assessments

WAB-R, BNT, CLQT,
CIUS, NAVS, ABA-2

WAB-R, BNT, CLQT, CIUS, NAVS, ABA-2

Maintenance Phase:
4 weeks after study
completion

Probes/outcome
measures

Probes/outcome measures
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APPENDIX F

SCRIPT TRAINING PROTOCOL
Minutes
1-15 minutes
15-25 minutes
25-35
35-45
45-60

•

Plan
Open period of conversation –Review of
today’s goals
Practice 1 Script
Practice 2nd Script
Practice 3rd Script
Review goals for session and homework
practice

For Script therapy, a review of the Script will be acquired and then the outcome
measures of sentence production ,fluency of discourse and, rate of speech will be
obtain at every session

Mastery of 3 Scripts:
1.) Hobbies
2.) Vacation
3.)Phone call

Treatment structure for Script Therapy. Each participant will be seen individually for
two 60 minutes sessions for 9 weeks. Treatment sessions will be structured to allow at
least 3 10-minutes episodes of practicing Scripts, interspersed with approximately 4
brief periods of relaxed open conversation. At the beginning of each session, the
participants will be audio and video recorded while practicing the Scripts or the
targeted verb sentences. The participants will be recorded during this data collection.
As Scripts became mastered and entered a random practice phase, treatment sessions
will end with approximately 10 minutes of Script conversation practice to promote
flexible use of Scripts. The home practice sessions will be prescribed twice daily for
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15 minutes each during which the participants practiced their Scripts via a tape
recorder.
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APPENDIX G

VNeST Treatment Protocol
Basic Daily Treatment Structure for VNeST (60 minutes)
Minutes
1-15 minutes
15-25 minutes
25-35
35-45
45-60

Plan
Open period of conversation –Review of
todays goals
Practice 8 trained verbs
Practice 8 trained verbs
Practice 8 trained verbs
Review goals for session and homework
practice

VNeST Stimuli Development. Stimuli will consist of 10 cards containing the names of
10 target verbs, six to eight cards for each verb containing three to four agents and
three to four patients that formed three to four pairs related to each verb. Additionally,
five cards containing the words who, what, where, when, and why and 12 sentences
for semantic judgment and 12 sentences containing the target verb broken into four
categories:
A. correct (“The designer measures the room.”),
B. inappropriate agent (“The infant measures the lumber.),
C. inappropriate patient (“The chef measures the television”),
D. thematic reversal (“The room measures the designer”) (Edmonds & Babb,
2011).
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VNeST will be administered two times per week for two one hour sessions for a total
of 9 weeks. During treatment, all participants will be asked to produce orally three to
four thematic pairs (e.g. carpenter and lumber) for a provided verb (e.g.
measure).When the participants are unable to produce a word, written options on
cards will be provided. In this protocol, the participants will generate three to four
agent pairs, then the participants will read each agent-patient pair aloud(the verb was
not read aloud)and then chose one answer to a wh-question. Probes will presented
during the beginning of each session (written or spoken). During treatment,
participants will be asked to produce orally three to four thematic role pairs
(e.g.,carpenter and lumber) for a provided verb (e.g.,measure). When they were
unable to produce a word, written options on cards will be provided (some
appropriate and some foils). Participants are encouraged to provide at least one
personal pair (e.g., dad/boat for drive), and responses could change from week to
week. In the original protocol (i.e., Edmonds et al., 2009), after generating three to
four appropriate agent-patient pairs, participants read each agent-patient pair aloud
(the verb was not read aloud) and chose one to answer wh-questions about it
(e.g.,when, where,or why). Following the protocol, when the participants are unable
to produce thematic role pairs for a provided verb; they are allowed to write their
responses. Criterion for ending treatment is met when participants produced a
minimum of 24 relevant agent-patient pairs (80% accuracy) during treatment Step 1
(e.g., for measure, acceptable pairs could include chef/sugar, wife/windows, or
designer/room).
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Treatment session structure for VNeST. Probe and control measures will be
administered at the beginning of each session. During administration, probe pictures
will be presented pseudorandomly with semantically related verbs (e.g.,bake/fry) in
nonsequential order. For each picture, participants will be instructed to make a
sentence and include him/her, the action, and this (while pointing to the agent
[carpenter], verb [measure], and patient [stairs]). Prompts will not be not provided
unless the participant produced a general word for the target (e.g.,cut instead of slice
or man instead of carpenter), for which a prompt for a more specific word was given.
Weekly probes will be administered in spoken and written modalities (on different
days) to assess potential improvement in both modalities. For the control task,
participants will be asked to complete sentences using a synonym for the provided
adjective (e.g., Someone who is sick is also said to be _____[target =ll).In the event
of multiple attempts, the adjective closest to the target will be scored.
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APPENDIX H

ERROR ANALYSIS
SALT Error rate per session for P1: Probes
Session
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18

Perseverations
IDK
2
3
2
5
3
3
2
0
3
2
3
1
4
14
11
5
0
14

6
4
4
3
3
1
2
0
2
3
1
2
0
2
6
3
0
0

Paraphasias
Incompleterepetitions
utterances
i nterjections
morphological
omissions
errorssubstitutions
3
2
1
3
3
1
0
6
5
2
2
5
0
1
4
1
2
2
3
0
0
9
7
9
4
5
2
1
4
1
9
2
10
0
0
1
2
5
1
8
2
1
4
1
1
3
2
2
0
3
1
2
2
2
0
1
6
1
1
0
2
4
2
3
2
4
0
0
4
0
3
1
1
3
4
2
1
4
1
1
2
2
3
1
3
4
2
4
4
2
1
8
9
2
3
11
0
2
10
11
2
6
2
0
1
6
0
2
6
5
3
3
5
4
2
3
3
2
1
3
1
1
0
11
1
0

SALT Error rate per session for P2: Probes
Session
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18

Perseverations
IDK
3
4
5
5
4
5
6
7
6
4
3
4
6
6
8
4
3
7

0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

Paraphasias
Incompleterepetitions
utterances
i nterjections
morphological
omissions
errorssubstitutions
6
1
4
0
0
0
0
5
2
3
0
3
0
0
6
4
2
0
7
0
0
4
0
2
0
5
0
2
7
3
2
0
6
0
0
6
0
1
0
5
0
0
5
1
2
0
4
3
0
4
0
3
0
6
1
2
12
0
0
0
5
2
2
8
5
2
0
11
2
0
9
4
0
0
4
0
2
6
2
0
0
4
0
4
5
4
3
0
7
3
0
4
4
0
1
6
0
1
4
2
3
0
7
0
7
5
3
2
0
4
0
1
4
2
0
0
3
0
1
8
2
0
0
8
0
3
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APPENDIX I

SAMPLE SCRIPT

Hobby Script #1
C: What are some of your hobbies?
P: I watch crime shows on TV.
P: investigation
C: What are these shows about?
P: The show is about a detective investigating a crime
C: What channel are these shows on?
P: We have cable
C: great
P: I like it because I take criminal justice classes
C: Oh, ok you took criminal justice classes in college
P: yes, I studied criminal justice
C: cool
P: I like these shows because you find out what the criminal did
C: What was your favorite class in college?
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P: I liked the forensic courses.
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